{"gene":"KCND3","run_date":"2026-04-28T18:06:54","timeline":{"discoveries":[{"year":1996,"finding":"Kv4.3 encodes a rapidly inactivating A-type K+ current (transient outward current, Ito) when expressed in heterologous systems, with biophysical and pharmacological properties matching native canine and human ventricular Ito.","method":"Heterologous expression and electrophysiology (whole-cell patch clamp) in Xenopus oocytes and cell lines","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 1 — functional reconstitution in heterologous system, replicated across multiple species and labs","pmids":["8831489"],"is_preprint":false},{"year":1997,"finding":"Kv4.3 exists as alternatively spliced isoforms (short and long, differing by a 19-amino acid insertion in the C-terminal intracellular region); the long isoform is predominant in rat heart and lung, while both isoforms produce functional A-type K+ currents.","method":"RT-PCR cloning and functional expression in HEK293 cells with whole-cell patch clamp","journal":"FEBS letters","confidence":"High","confidence_rationale":"Tier 1 — molecular cloning plus functional electrophysiological characterization","pmids":["9450548","9314834"],"is_preprint":false},{"year":1997,"finding":"Kv4.3 is expressed in rat hippocampus and multiple CNS regions and produces an A-type K+ current when expressed in Xenopus oocytes, consistent with a role in controlling subthreshold A-currents and neuronal excitability.","method":"cDNA cloning, functional expression in Xenopus oocytes, in situ hybridization","journal":"FEBS letters","confidence":"High","confidence_rationale":"Tier 1 — reconstitution in oocytes plus regional expression mapping","pmids":["9001401"],"is_preprint":false},{"year":2000,"finding":"KChIP2 auxiliary subunits associate with Kv4.3, increase current density, slow current decay in a Ca2+-dependent manner, and hasten recovery from inactivation; a steep transmural gradient of KChIP2 mRNA (but not protein) exists in human/canine ventricle.","method":"Heterologous co-expression, whole-cell patch clamp, kinetic RT-PCR, Western blot, immunocytochemistry","journal":"Circulation","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods, replicated across labs","pmids":["12135940"],"is_preprint":false},{"year":2000,"finding":"Kv4.3 associates with Kvβ2 subunits in brain; Kvβ1 or Kvβ2 co-expression increases Kv4.3 current density and protein expression (by stabilizing the protein) without affecting channel gating; this interaction requires the C-terminus but not N-terminus of Kv4.3.","method":"Co-immunoprecipitation, transfection/expression in heterologous cells, whole-cell patch clamp, protein stability assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-IP plus functional electrophysiology with domain-mapping mutagenesis","pmids":["11087728"],"is_preprint":false},{"year":2000,"finding":"Nicotine directly blocks Kv4.3 channels (IC50 ~40 nM) by both tonic and use-dependent block, reducing single-channel conductance, open probability, and open time, without altering activation kinetics; this effect is receptor-independent.","method":"Whole-cell and single-channel patch clamp in Xenopus oocytes and canine ventricular myocytes","journal":"Circulation","confidence":"High","confidence_rationale":"Tier 1 — in vitro functional assay at multiple levels (whole-cell and single-channel), with pharmacological controls","pmids":["10973847"],"is_preprint":false},{"year":2000,"finding":"In vivo overexpression of Kv4.3 by adenoviral gene transfer in guinea pig myocytes produces robust Ito, depresses the plateau potential, and abbreviates action potential duration; dominant-negative Kv4.3-W362F suppresses Ito in rats, elevates plateau height, prolongs APD by ~30%, and prolongs QT interval.","method":"In vivo adenoviral gene transfer, whole-cell patch clamp, surface ECG recordings","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 — clean loss- and gain-of-function in vivo with defined electrophysiological phenotype","pmids":["10772652"],"is_preprint":false},{"year":2001,"finding":"Angiotensin II (Ang II) downregulates Kv4.3 mRNA by destabilizing the transcript (via mRNA half-life reduction), while phenylephrine (PE) downregulates Kv4.3 mRNA via transcriptional repression of the Kv4.3 promoter; the two pathways act independently.","method":"RNase protection assays, mRNA turnover measurements, Kv4.3 promoter-reporter assays in neonatal rat cardiac myocytes, immunoblots","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal mechanistic approaches distinguishing transcriptional vs. post-transcriptional regulation","pmids":["11249870"],"is_preprint":false},{"year":2002,"finding":"KChIP auxiliary subunits modulate Kv4.3 inactivation and recovery via distinct structural domains: the EF-hand modulates effects on inactivation but not recovery; Ca2+-independent effects on recovery are mediated through a short non-EF-hand stretch; closed-state inactivation is Ca2+-independent while open-state inactivation is Ca2+-dependent.","method":"Cloning of minimal KChIP2d isoform, heterologous expression in Xenopus oocytes, whole-cell patch clamp with mutagenesis","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 1 — domain-specific mutagenesis plus functional electrophysiology","pmids":["12433945"],"is_preprint":false},{"year":2002,"finding":"Palmitoylation of KChIP2 isoforms at N-terminal cysteine residues is required for plasma membrane localization of KChIP2 and for efficient trafficking and increased surface expression of associated Kv4.3 channels; metabolic labeling confirmed palmitoylation at these cysteines.","method":"Metabolic labeling (palmitoylation assay), site-directed mutagenesis, confocal microscopy, whole-cell patch clamp","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — metabolic labeling plus mutagenesis with functional readout","pmids":["12006572"],"is_preprint":false},{"year":2002,"finding":"KChIP2b modulates Kv4.3 gating via inner pore structure; mutation of inner pore residues V399I/V401I reveals that the inner pore is important for the modulatory effect of KChIP2b on inactivation kinetics; KChIP2b increases rate of recovery from inactivation of both WT and mutant channels.","method":"Site-directed mutagenesis, heterologous expression, whole-cell patch clamp","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 1 — mutagenesis plus electrophysiology; single lab, single paper","pmids":["12150935"],"is_preprint":false},{"year":2002,"finding":"Kv4.3 exhibits a C-type (external pore collapse) inactivation mechanism; removal of external K+ destabilizes the conducting state by collapsing the selectivity filter pore, consistent with C-type inactivation.","method":"Whole-cell voltage clamp, manipulation of external K+ concentration, biophysical analysis","journal":"The Journal of membrane biology","confidence":"Medium","confidence_rationale":"Tier 1 — in vitro biophysical assay; single lab, single paper","pmids":["12172648"],"is_preprint":false},{"year":2004,"finding":"CaMKII directly phosphorylates Kv4.3 at residue S550A in the C-terminal region, slowing inactivation and accelerating recovery from inactivation; mutation S550A abolishes these CaMKII effects, establishing S550 as the CaMKII target site.","method":"Site-directed mutagenesis, intracellular dialysis of autophosphorylated CaMKII, whole-cell patch clamp","journal":"American journal of physiology. Cell physiology","confidence":"High","confidence_rationale":"Tier 1 — in vitro kinase assay with mutagenesis identifying specific phosphorylation site","pmids":["15456698"],"is_preprint":false},{"year":2004,"finding":"KChIP2 isoforms modulate Kv4.3 gating by accelerating recovery from inactivation, slowing closed-state inactivation, and promoting open-state inactivation; Ca2+-dependent effects operate selectively through open-state inactivation, while closed-state inactivation transitions are Ca2+-independent.","method":"Xenopus oocyte expression, whole-cell patch clamp with detailed kinetic modeling","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 1 — detailed kinetic analysis with mechanistic model","pmids":["14724186"],"is_preprint":false},{"year":2004,"finding":"Angiotensin receptor type 1 (AT1R) forms a physical complex with Kv4.3 and KChIP2 in canine ventricular cells and HEK293 cells; Ang II treatment causes co-internalization of Kv4.3 with AT1R and shifts the activation voltage threshold of remaining surface Kv4.3 channels to more positive values.","method":"Co-immunoprecipitation, FRET, fluorescence co-localization (ECFP/EYFP-tagged proteins), whole-cell patch clamp","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-IP plus FRET with functional electrophysiological phenotype","pmids":["15342638"],"is_preprint":false},{"year":2004,"finding":"In vivo Kv4.3 gene transfer in rats with aortic stenosis restores Ito density, shortens action potential duration, and abrogates the hypertrophic response by reducing calcineurin and NFATc1 expression, placing Kv4.3 upstream of the calcineurin/NFAT hypertrophic pathway.","method":"In vivo adenoviral gene transfer, whole-cell patch clamp, Western blot, heart weight measurements","journal":"Circulation","confidence":"High","confidence_rationale":"Tier 2 — in vivo gene transfer with epistatic pathway placement via calcineurin/NFAT","pmids":["15557376"],"is_preprint":false},{"year":2005,"finding":"DPPX (DPP6) acts as an additional beta-subunit of Kv4.3 in human heart; co-expression of DPPX with Kv4.3 and KChIP2a reconstitutes native human cardiac Ito kinetics (faster inactivation, more negative half-inactivation, delayed recovery compared to Kv4.3+KChIP2a alone).","method":"Quantitative RT-PCR, Western blot with DPPX-specific antibody, co-expression in CHO cells, whole-cell patch clamp","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 1-2 — reconstitution of native current properties plus protein detection in human heart","pmids":["15890703"],"is_preprint":false},{"year":2006,"finding":"Ang II and mechanical stretch activate NADPH oxidase (via AT1 receptors, superoxide, and ASK1-p38 kinase signaling) to specifically destabilize Kv4.3 channel mRNA through sequences in the 3'-UTR, while Kv4.2 and Kv1.5 3'-UTRs are insensitive.","method":"Reporter construct assays with Kv4.3 3'-UTR, dominant-negative Rac, NADPH oxidase inhibitors, SOD/catalase overexpression, kinase inhibitors in neonatal rat cardiac myocytes","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 — multiple pharmacological and genetic perturbations with specific molecular readout","pmids":["16556864"],"is_preprint":false},{"year":2006,"finding":"DPP10 modulates Kv4.3 inactivation by causing negative shifts in steady-state activation and inactivation and promoting closed-state inactivation, through its transmembrane and short cytoplasmic domain; DPP10 and KChIP2b have different primary effects (closed-state vs. open-state inactivation respectively).","method":"Heterologous co-expression, whole-cell patch clamp, truncation mutagenesis of DPP10","journal":"American journal of physiology. Cell physiology","confidence":"High","confidence_rationale":"Tier 1 — functional reconstitution with domain-mapping mutagenesis","pmids":["16738002"],"is_preprint":false},{"year":2006,"finding":"CaMKII co-immunoprecipitates with Kv4.3 (but not Kv4.2) in rat cardiac myocytes without prior Ca2+ elevation; CaMKII phosphorylates Kv4.3 at baseline, slowing its inactivation; Kv4.3 acts as a molecular scaffold concentrating CaMKII at the membrane, enabling Ca2+-dependent modulation of associated Kv4.2 channels.","method":"Co-immunoprecipitation, Western blot with phospho-specific antibodies, whole-cell patch clamp in myocytes and HEK cells","journal":"American journal of physiology. Heart and circulatory physiology","confidence":"High","confidence_rationale":"Tier 2 — co-IP with biochemical and electrophysiological validation","pmids":["16648177"],"is_preprint":false},{"year":2007,"finding":"Kv4.3 mediates A-type K+ currents in CA1 LM/RAD hippocampal interneurons and is required for subthreshold membrane potential oscillations; siRNA knockdown of Kv4.3 selectively impairs A-type K+ currents and MPOs in these interneurons.","method":"siRNA knockdown, whole-cell patch clamp, immunolabeling in hippocampal slices","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — loss-of-function siRNA with specific electrophysiological phenotype","pmids":["17314290"],"is_preprint":false},{"year":2008,"finding":"AUF1 (ARE/poly-U binding/degradation factor 1) is upregulated by Ang II via AT1R-NADPH oxidase-p38 MAPK signaling; AUF1 binds to an AU-rich element (ARE) in the Kv4.3 3'-UTR to destabilize the channel mRNA; overexpression of AUF1 mimics and occludes the Ang II effect, and siRNA against AUF1 blocks it.","method":"Deletion and mutagenesis of 3'-UTR ARE, AUF1 overexpression and siRNA knockdown, RNA pulldown assays, reporter assays","journal":"Journal of molecular and cellular cardiology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal approaches identifying specific mRNA-destabilizing mechanism","pmids":["18789946"],"is_preprint":false},{"year":2008,"finding":"KCNE2 (MiRP1) co-assembles with Kv4.3 and reduces peak current density, slows inactivation, and shifts steady-state inactivation positively, making Kv4.3 more like native cardiac Ito; KCNE2 variants M54T and I57T cause gain-of-function by increasing current density.","method":"Heterologous co-expression in cell lines, whole-cell patch clamp","journal":"Heart rhythm","confidence":"Medium","confidence_rationale":"Tier 2 — functional reconstitution; single lab, no structural validation","pmids":["20042375"],"is_preprint":false},{"year":2008,"finding":"KChIP4a crystal structure at 3.0 Å resolution shows distinct N-terminal alpha-helices; competitive binding of the Kv4.3 N-terminal peptide to the hydrophobic groove of KChIP4a displaces the KChIP4a N-terminus, which acts as a slow inactivation gate suppressing Kv4.3 inactivation.","method":"X-ray crystallography, biochemical binding assays, electrophysiology, N-terminal peptide fusion experiments","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — crystal structure plus biochemical and functional validation","pmids":["19109250"],"is_preprint":false},{"year":2009,"finding":"Nerve injury causes NRSF to bind the NRSE element in the Kv4.3 gene promoter in dorsal root ganglion neurons, leading to deacetylation of histone H4 at the NRSE (epigenetic silencing) and long-lasting Kv4.3 mRNA downregulation; NRSF antisense knockdown blocks this effect.","method":"ChIP assay for NRSF binding and histone acetylation, RT-PCR, antisense knockdown in vivo","journal":"Neuroscience","confidence":"High","confidence_rationale":"Tier 2 — ChIP assay with antisense rescue establishing epigenetic mechanism","pmids":["20006971"],"is_preprint":false},{"year":2009,"finding":"Alanine scanning of the Kv4.3 S3b region identifies L275 and V276 as critical residues for interaction with HpTx2 (an ICK gating modifier toxin); KChIP2b stabilizes the closed state of Kv4.3, increasing HpTx2 affinity; the S3b hydrophobic character is the primary determinant of toxin binding.","method":"Site-directed mutagenesis, functional expression, concentration-response electrophysiology","journal":"Molecular pharmacology","confidence":"Medium","confidence_rationale":"Tier 1 — systematic mutagenesis of binding site; single lab","pmids":["19357248"],"is_preprint":false},{"year":2009,"finding":"Thyroid hormone receptor alpha1 (TRα1) activates KCND3 transcription via a response element at -1651 bp, while TRβ1 suppresses KCND3 transcription via a different response element at -73 bp; both effects are ligand-dependent; TRα1 increases Ito and TRβ1 reduces Ito in cardiomyocytes.","method":"Adenoviral gene transfer, promoter-reporter constructs, mutagenesis of TR binding sites, whole-cell patch clamp in rat cardiomyocytes","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 2 — promoter deletion and mutagenesis with functional electrophysiological readout","pmids":["19171649"],"is_preprint":false},{"year":2009,"finding":"Ang II downregulates Kv4.3 mRNA and protein in RVLM neurons via AT1R-ROS-p38 MAPK signaling, decreasing A-type K+ current and increasing neuronal excitability; this mechanism contributes to sympathoexcitation in chronic heart failure.","method":"GeneChip screening, RT-PCR, Western blot, whole-cell patch clamp in CATH.a neurons, microinjection in intact animals, kinase inhibitors","journal":"American journal of physiology. Heart and circulatory physiology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple methods in neuronal cell line; in vivo corroboration with microinjection","pmids":["20044444"],"is_preprint":false},{"year":2010,"finding":"Kv4.3 and inactive CaMKII form a complex at the cardiomyocyte membrane (shown by co-IP and FRET); Kv4.3 blocks CaMKII activation by binding to the calmodulin binding sites; dissociation of CaMKII from the Kv4.3-CaMKII complex releases these sites and leads to CaMKII autophosphorylation and L-type Ca2+ current facilitation. Kv4.3 overexpression reduces basal CaMKII autophosphorylation.","method":"Co-immunoprecipitation, FRET, L-type Ca2+ current recordings, Ca2+ chelation (BAPTA vs. EGTA), Kv4.3 overexpression in myocytes","journal":"European heart journal","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-IP plus FRET plus functional electrophysiological consequences","pmids":["21148163"],"is_preprint":false},{"year":2010,"finding":"Kv4.2, Kv4.3, and Kv1.4 alpha-subunits encode three distinct, separable components of the macroscopic IA current in mouse cortical pyramidal neurons, as determined by targeted gene deletion.","method":"Genetic knockout (Kv4.2-/-, Kv4.3-/-, double and compound knockouts), whole-cell patch clamp with pharmacological blockers","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — clean genetic loss-of-function with specific electrophysiological phenotype","pmids":["20371829"],"is_preprint":false},{"year":2011,"finding":"PKCα is the primary isoenzyme mediating PKC-dependent reduction of Kv4.3 current; conventional PKC activation reduces Kv4.3 current in a PKCα-dependent manner (blocked by PKCα siRNA and HBDDE), while novel PKC isoforms have no significant effect.","method":"Xenopus oocyte expression with double electrode voltage clamp, siRNA knockdown of PKC isoforms, pharmacological activators/inhibitors, patch clamp in rat cardiomyocytes","journal":"Journal of molecular and cellular cardiology","confidence":"High","confidence_rationale":"Tier 2 — siRNA plus pharmacological isoenzyme-selective perturbation with functional readout","pmids":["21803046"],"is_preprint":false},{"year":2011,"finding":"Two KCND3 gain-of-function mutations (L450F and G600R) associated with Brugada syndrome increase peak Ito current density by 146% and 50%, respectively, when co-expressed with KChIP2 in HEK293 cells; simulation modeling shows that increased Ito causes loss of the action potential dome.","method":"Site-directed mutagenesis, co-expression with KChIP2, whole-cell patch clamp in HEK293 cells, Luo-Rudy AP simulation","journal":"Heart rhythm","confidence":"High","confidence_rationale":"Tier 2 — functional reconstitution with mutagenesis and computational modeling","pmids":["21349352"],"is_preprint":false},{"year":2012,"finding":"KCND3 loss-of-function mutations causing SCA19/22 (T352P, M373I, S390N, F227del, G345V, V338E, T377M) result in ER retention, protein instability, and absent or reduced K+ channel current; KChIP2 can rescue membrane localization and stability of some mutants but does not fully restore channel function.","method":"Whole exome sequencing, site-directed mutagenesis, heterologous expression in HeLa cells, immunofluorescence, patch-clamp electrophysiology, autopsy immunohistochemistry","journal":"Annals of neurology","confidence":"High","confidence_rationale":"Tier 2 — two independent studies with orthogonal methods, multiple mutations characterized","pmids":["23280837","23280838"],"is_preprint":false},{"year":2012,"finding":"Large T-antigen upregulates Kv4.3 expression through increasing the transcription factor Sp1; Sp1 decoy oligonucleotides reduce Kv4.3 expression; Kv4.3 inhibition (via 4-AP or siRNA) induces cell apoptosis and necrosis through CaMKII activation (prevented by KN-93).","method":"Sp1 decoy oligonucleotides, Sp1 overexpression vector, Kv4.3 siRNA, pharmacological blockers, cell death assays, KN-93 rescue in HEK293/HEK293T cells","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 2 — multiple genetic and pharmacological perturbations; single lab","pmids":["22023388"],"is_preprint":false},{"year":2009,"finding":"Closed-state inactivation (CSI) of Kv4.3 isoforms is differentially regulated by PKC: PMA reduces CSI in Kv4.3-S but increases CSI in Kv4.3-L; mutation of T504 (a PKC site unique to the 19-amino acid insert of Kv4.3-L) to aspartate eliminates the PMA response, identifying T504 as the isoform-specific PKC phosphorylation site.","method":"Site-directed mutagenesis, Xenopus oocyte expression with double electrode voltage clamp, PMA and purified PKC treatment","journal":"American journal of physiology. Cell physiology","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis identifying specific phosphorylation site with isoform-selective functional consequence","pmids":["19675305"],"is_preprint":false},{"year":2014,"finding":"NS5806 binds to a hydrophobic site on the C-terminus of KChIP3 in a Ca2+-dependent manner (Kd 2-5 μM), increasing the affinity between KChIP3 and the N-terminus of Kv4.3 and decreasing the rate of their dissociation; Tyr-174 and Phe-218 on KChIP3 are required for this drug-induced enhancement.","method":"Fluorescence spectroscopy, isothermal titration calorimetry, docking simulations, site-directed mutagenesis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — biophysical binding measurements plus mutagenesis identifying specific interface residues","pmids":["25228688"],"is_preprint":false},{"year":2014,"finding":"SEMA3A (semaphorin 3A) selectively inhibits Kv4.3 (but not Nav1.5, Cav1.2, or Kv4.2) by directly binding to Kv4.3, reducing peak current density without altering surface protein expression; co-immunoprecipitation confirms physical interaction; disruption of a putative toxin-binding domain on Kv4.3 disrupts SEMA3A inhibition.","method":"Co-immunoprecipitation, whole-cell patch clamp in HEK293 cells and hiPSC-derived cardiomyocytes, domain disruption mutagenesis, perfusion experiments","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 — co-IP plus domain mutagenesis plus functional electrophysiology in multiple systems","pmids":["24963029"],"is_preprint":false},{"year":2015,"finding":"SCA19/22-mutant Kv4.3 subunits exert dominant negative effects on wild-type Kv4.3 trafficking and surface expression in the absence of KChIP2; KChIP2 co-expression rescues this dominant negative effect on trafficking; all tested mutants either suppress WT Kv4.3 current amplitude or alter gating in a dominant manner.","method":"Co-expression of mutant and WT Kv4.3, immunofluorescence for localization, whole-cell patch clamp","journal":"Cellular and molecular life sciences","confidence":"High","confidence_rationale":"Tier 2 — multiple SCA mutations tested with rescue by KChIP2; dominant-negative mechanism established","pmids":["25854634"],"is_preprint":false},{"year":2015,"finding":"A de novo KCND3 mutation (p.Arg293_Phe295dup) duplicating the RVF motif in the voltage-sensor domain causes a severe positive shift in voltage-dependence of gating and markedly reduced channel opening, correlating with a severe SCA19/22 phenotype with intellectual disability, epilepsy, and ataxia.","method":"Whole exome sequencing, immunocytochemistry, immunoblotting, patch clamp assays","journal":"BMC medical genetics","confidence":"Medium","confidence_rationale":"Tier 2 — functional characterization of de novo variant; single case/lab","pmids":["26189493"],"is_preprint":false},{"year":2019,"finding":"Novel SCA19/22-associated KCND3 mutations (C317Y, P375S, V338E, T377M) cause loss-of-function with enhanced protein degradation and defective membrane trafficking; co-expression of mutant subunits with WT KV4.3 demonstrates dominant-negative effects on protein biosynthesis and voltage-dependent gating.","method":"Targeted NGS, heterologous expression, electrophysiology, Western blot for protein stability, immunofluorescence for trafficking, co-expression with WT channel","journal":"Human mutation","confidence":"High","confidence_rationale":"Tier 2 — multiple mutations with orthogonal biochemical and functional readouts; dominant-negative mechanism directly demonstrated","pmids":["31293010"],"is_preprint":false},{"year":2008,"finding":"KChIP1 co-expression modulates Kv4.3 A-type K+ currents in HEK293 cells (faster recovery, leftward activation shift, faster rise time, slower decay); in hippocampal LM/RAD interneurons, KChIP1 siRNA knockdown slows recovery from inactivation and increases firing frequency during sustained depolarization, indicating KChIP1 regulates Kv4.3-based interneuron excitability.","method":"HEK293 co-expression electrophysiology, siRNA knockdown in hippocampal slice cultures, whole-cell patch clamp","journal":"Neuroscience","confidence":"High","confidence_rationale":"Tier 2 — siRNA knockdown in native neurons with defined excitability phenotype, corroborated by heterologous system","pmids":["21129448"],"is_preprint":false},{"year":2020,"finding":"Alternative isoforms of Kv4 auxiliary subunits (KChIP1 vs. KChIP4e and DPP6S) determine distinct firing phenotypes of CCK+ hippocampal interneurons by differentially modulating Kv4.3-mediated low-voltage-activated K+ currents, despite comparable Kv4.3 expression levels in both cell types.","method":"Patch clamp electrophysiology in hippocampal slices, immunohistochemistry, transcriptomic profiling, pharmacology","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal approaches linking specific auxiliary subunit isoforms to distinct electrophysiological phenotypes in native interneurons","pmids":["32490811"],"is_preprint":false},{"year":2021,"finding":"Downregulation of Kv4.3 in nociceptive trigeminal ganglion neurons after infraorbital nerve injury reduces IA currents and underlies cold hypersensitivity; pharmacological inhibition of Kv4.3 (phrixotoxin-2) recapitulates cold allodynia, while pharmacological potentiation of Kv4.3 alleviates it in ION-CCI rats.","method":"Immunostaining, patch-clamp of acutely dissociated TG neurons, orofacial operant behavioral testing, pharmacological manipulation in vivo","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — loss-of-function and gain-of-function pharmacological manipulation with defined behavioral and electrophysiological phenotypes","pmids":["33472822"],"is_preprint":false},{"year":2021,"finding":"miR-27a-3p targets the 3'-UTR of Hoxa10, reducing Hoxa10 protein expression; Hoxa10 positively regulates Kv4.3 expression; miR-27a-3p inhibition or Hoxa10 overexpression alleviates Ang II-induced cardiomyocyte hypertrophy and restores Kv4.3 levels, establishing a miR-27a-3p/Hoxa10/Kv4.3 regulatory axis.","method":"Luciferase reporter assay, miRNA inhibitor transfection, Hoxa10 overexpression, Western blot, patch clamp","journal":"Frontiers in pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 — luciferase assay plus rescue experiments; single lab","pmids":["34248630"],"is_preprint":false}],"current_model":"KCND3-encoded Kv4.3 is a voltage-gated K+ channel alpha-subunit that assembles with auxiliary subunits (KChIP1-4, Kvβ, DPPX/DPP6, DPP10, KCNE2/MiRP1) into macromolecular complexes at the plasma membrane to generate the fast transient outward K+ current (Ito) in heart and A-type K+ current (IA) in neurons; its trafficking, surface expression, and gating are regulated by KChIP palmitoylation, CaMKII phosphorylation at S550, PKCα phosphorylation at isoform-specific sites, Ang II-AT1R signaling through NADPH oxidase/p38 MAPK/AUF1-mediated mRNA destabilization, NRSF-mediated epigenetic silencing, thyroid hormone receptor isoforms, and physical interaction with AT1R and SEMA3A; in cardiomyocytes Kv4.3 sequesters inactive CaMKII, suppressing pathological CaMKII activation, while loss-of-function mutations cause SCA19/22 cerebellar ataxia via dominant-negative ER retention and gain-of-function mutations cause J-wave syndromes and arrhythmias via enhanced Ito."},"narrative":{"teleology":[{"year":1996,"claim":"Establishing KCND3 as the molecular identity of Ito resolved which gene encodes the fast transient outward K⁺ current in ventricular myocytes.","evidence":"Heterologous expression in Xenopus oocytes and cell lines reproduced biophysical and pharmacological properties of native canine/human ventricular Ito","pmids":["8831489"],"confidence":"High","gaps":["No auxiliary subunit contributions yet defined","Native channel complex composition unknown"]},{"year":1997,"claim":"Discovery of alternative splicing and CNS expression expanded Kv4.3 from a cardiac channel to a broadly expressed neuronal A-type K⁺ current generator.","evidence":"RT-PCR cloning identified short and long isoforms differing by 19 amino acids; in situ hybridization mapped expression in hippocampus and multiple CNS regions; both isoforms produced functional currents","pmids":["9450548","9314834","9001401"],"confidence":"High","gaps":["Functional consequence of the 19-aa insert unknown","Relative contribution to neuronal IA vs. Kv4.2 not established"]},{"year":2000,"claim":"Identification of KChIP and Kvβ auxiliary subunits as Kv4.3 partners explained how native Ito properties diverge from recombinant Kv4.3 alone and how the channel is stabilized and trafficked.","evidence":"Co-IP, co-expression electrophysiology, and protein stability assays showed KChIP2 increases current density in a Ca²⁺-dependent manner and Kvβ stabilizes Kv4.3 protein via C-terminal interaction","pmids":["12135940","11087728"],"confidence":"High","gaps":["Full stoichiometry of the native complex not determined","KChIP transmural gradient mechanism not resolved"]},{"year":2000,"claim":"In vivo gain- and loss-of-function demonstrated that Kv4.3 is rate-limiting for action potential duration and QT interval, establishing its physiological necessity.","evidence":"Adenoviral Kv4.3 overexpression in guinea pig created Ito and shortened APD; dominant-negative Kv4.3-W362F in rat prolonged APD by ~30% and prolonged QT","pmids":["10772652"],"confidence":"High","gaps":["Long-term consequences of Kv4.3 manipulation on arrhythmia susceptibility not tested","Compensatory remodeling of other K⁺ channels not excluded"]},{"year":2002,"claim":"Mapping the KChIP–Kv4.3 gating interface and demonstrating palmitoylation-dependent trafficking resolved how auxiliary subunits control both channel biophysics and surface expression.","evidence":"EF-hand mutagenesis separated Ca²⁺-dependent open-state from Ca²⁺-independent closed-state inactivation modulation; metabolic labeling confirmed KChIP2 palmitoylation at N-terminal cysteines is required for plasma membrane targeting of the complex","pmids":["12433945","12006572","12150935"],"confidence":"High","gaps":["Identity of the palmitoyl transferase unknown","Structural basis of KChIP-Kv4.3 interaction at atomic level not yet available"]},{"year":2004,"claim":"Discovery of CaMKII phosphorylation at S550 and AT1R–Kv4.3 complex formation revealed that the channel is both a kinase substrate and a signaling scaffold.","evidence":"CaMKII dialysis slowed inactivation abolished by S550A mutation; co-IP and FRET showed AT1R physically associates with Kv4.3/KChIP2, and Ang II causes co-internalization","pmids":["15456698","15342638"],"confidence":"High","gaps":["Whether S550 phosphorylation occurs tonically in vivo unresolved","Structural basis of AT1R–Kv4.3 interaction unknown"]},{"year":2004,"claim":"Kv4.3 gene transfer in pressure-overloaded hearts reversed hypertrophy by suppressing calcineurin/NFAT, placing Kv4.3 upstream of a major hypertrophic signaling pathway.","evidence":"Adenoviral Kv4.3 in aortic-banded rats restored Ito, shortened APD, and reduced calcineurin/NFATc1 expression and heart weight","pmids":["15557376"],"confidence":"High","gaps":["Whether the anti-hypertrophic effect is purely electrophysiological or also involves CaMKII sequestration not dissected"]},{"year":2006,"claim":"Identification of DPPX and DPP10 as additional auxiliary subunits completed the reconstitution of native Ito/IA kinetics and showed that distinct accessory proteins control closed-state versus open-state inactivation.","evidence":"DPPX + KChIP2a + Kv4.3 co-expression in CHO cells reconstituted native human cardiac Ito; DPP10 truncation mutagenesis showed its transmembrane domain promotes closed-state inactivation","pmids":["15890703","16738002"],"confidence":"High","gaps":["Relative stoichiometry of DPPX vs. DPP10 in different tissues unknown","Whether DPPX and KChIP compete or co-assemble simultaneously not fully resolved"]},{"year":2006,"claim":"Delineation of the Ang II–NADPH oxidase–p38 MAPK–AUF1 axis targeting Kv4.3 3ʹ-UTR explained the post-transcriptional mechanism of Ito remodeling in hypertrophy and heart failure.","evidence":"Reporter constructs with Kv4.3 3ʹ-UTR, dominant-negative Rac, NADPH oxidase inhibitors, and AUF1 overexpression/siRNA showed specificity for Kv4.3 mRNA destabilization via an AU-rich element","pmids":["16556864","18789946"],"confidence":"High","gaps":["Whether other ARE-binding proteins besides AUF1 contribute not excluded","In vivo validation of AUF1 role in intact heart not performed"]},{"year":2009,"claim":"PKCα was identified as the specific conventional PKC isoform reducing Kv4.3 current, with T504 in the long-isoform 19-aa insert as the isoform-selective phosphorylation site controlling closed-state inactivation.","evidence":"PKCα siRNA and selective inhibitors blocked current reduction; T504D mutation in Kv4.3-L eliminated PMA response","pmids":["21803046","19675305"],"confidence":"High","gaps":["Whether PKCα and CaMKII phosphorylation interact at the channel level not tested","In vivo relevance of T504 phosphorylation not demonstrated"]},{"year":2009,"claim":"NRSF-mediated epigenetic silencing of Kv4.3 after nerve injury explained persistent IA downregulation and neuropathic pain sensitization at a chromatin level.","evidence":"ChIP showed NRSF binding to NRSE in Kv4.3 promoter with H4 deacetylation in DRG neurons; NRSF antisense blocked Kv4.3 downregulation","pmids":["20006971"],"confidence":"High","gaps":["Identity of the HDAC recruited by NRSF at Kv4.3 locus unknown","Whether this mechanism operates in cardiac remodeling not tested"]},{"year":2010,"claim":"Demonstration that Kv4.3 sequesters inactive CaMKII at the membrane established a non-conducting signaling function: Kv4.3 loss releases CaMKII, enabling pathological autophosphorylation and L-type Ca²⁺ current facilitation.","evidence":"Co-IP and FRET confirmed Kv4.3–CaMKII complex; Kv4.3 overexpression reduced basal CaMKII autophosphorylation; CaMKII release enhanced ICa,L facilitation","pmids":["21148163"],"confidence":"High","gaps":["Structural basis of CaMKII–Kv4.3 interaction not resolved","Relative contribution of conducting vs. scaffolding function in disease not quantified"]},{"year":2012,"claim":"Identification of KCND3 loss-of-function mutations causing SCA19/22 via ER retention and dominant-negative suppression of wild-type channel trafficking established Kv4.3 as essential for cerebellar function.","evidence":"Whole exome sequencing in multiple families; mutant channels showed ER retention, protein instability, absent/reduced current; co-expression with WT demonstrated dominant-negative effects rescued partially by KChIP2","pmids":["23280837","23280838","25854634","31293010"],"confidence":"High","gaps":["Which cerebellar neuron subtypes are most vulnerable not defined","Whether KChIP rescue is therapeutically exploitable not tested"]},{"year":2011,"claim":"KCND3 gain-of-function mutations linked to Brugada syndrome demonstrated that excessive Ito causes J-wave arrhythmias by eliminating the action potential dome.","evidence":"L450F and G600R mutations co-expressed with KChIP2 in HEK293 cells showed 50–146% increased peak current; Luo-Rudy simulation modeled dome loss","pmids":["21349352"],"confidence":"High","gaps":["Patient-derived cardiomyocyte validation not performed","Whether other Ito-related genes modify penetrance not examined"]},{"year":2014,"claim":"SEMA3A was identified as a novel direct Kv4.3 inhibitor acting through the toxin-binding domain, revealing a non-canonical extracellular regulation of Ito independent of surface expression changes.","evidence":"Co-IP confirmed physical Kv4.3–SEMA3A interaction; domain mutagenesis disrupted inhibition; current reduction without surface expression change in HEK293 and hiPSC-cardiomyocytes","pmids":["24963029"],"confidence":"High","gaps":["Whether endogenous SEMA3A levels regulate cardiac Ito in vivo unknown","Binding affinity and stoichiometry not quantified"]},{"year":2020,"claim":"Combinatorial assembly of distinct KChIP and DPP isoforms with Kv4.3 was shown to determine cell-type-specific firing phenotypes in hippocampal interneurons, establishing auxiliary subunit identity as the primary determinant of functional diversity.","evidence":"Patch clamp, immunohistochemistry, and transcriptomics in CCK⁺ interneurons showed KChIP1 vs. KChIP4e/DPP6S produce distinct firing despite comparable Kv4.3 levels","pmids":["32490811"],"confidence":"High","gaps":["Whether auxiliary subunit composition changes dynamically with activity not known","Contribution of Kv4.2 heteromers not fully excluded"]},{"year":2021,"claim":"Kv4.3 downregulation in trigeminal nociceptors was shown to underlie cold hypersensitivity after nerve injury, and pharmacological Kv4.3 potentiation reversed cold allodynia, validating Kv4.3 as a pain target.","evidence":"Immunostaining and patch clamp in TG neurons after ION-CCI; phrixotoxin-2 recapitulated allodynia; Kv4.3 potentiation alleviated it behaviorally","pmids":["33472822"],"confidence":"High","gaps":["Identity of the Kv4.3 potentiator drug and its selectivity profile not fully characterized","Whether central Kv4.3 changes also contribute not addressed"]},{"year":null,"claim":"High-resolution structures of intact Kv4.3 channel complexes with auxiliary subunits, the precise stoichiometry and spatial organization of the native macromolecular complex, and the relative contributions of Kv4.3's conducting versus CaMKII-scaffolding functions to cardiac and neuronal disease remain to be determined.","evidence":"","pmids":[],"confidence":"Low","gaps":["No cryo-EM or crystal structure of the full Kv4.3–KChIP–DPP ternary complex","Relative pathogenic contribution of ion conduction loss vs. CaMKII desequestration not dissected in disease models","Therapeutic potential of auxiliary-subunit-targeted interventions for SCA19/22 untested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[0,1,2,6,20,29]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[28,33]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,6,9,14,28,32]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[32,39]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[4,19]}],"pathway":[{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[2,20,29,40,41,42]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[7,14,17,21,27,28]},{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[0,1,6,31]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[31,32,38,39]}],"complexes":["Kv4.3/KChIP2/DPPX ternary channel complex","Kv4.3/AT1R/KChIP2 signaling complex","Kv4.3/CaMKII scaffolding complex"],"partners":["KCNIP2","KCNIP1","KCNIP3","DPP6","DPP10","KCNAB2","KCNE2","AGTR1"],"other_free_text":[]},"mechanistic_narrative":"KCND3 encodes the Kv4.3 voltage-gated potassium channel α-subunit, which generates the fast transient outward K⁺ current (Ito) in cardiomyocytes and the A-type K⁺ current (IA) in neurons, thereby shaping action potential repolarization, neuronal excitability, and subthreshold membrane potential oscillations [PMID:8831489, PMID:10772652, PMID:17314290]. Kv4.3 assembles into macromolecular complexes with auxiliary subunits—KChIP1–4, Kvβ, DPPX/DPP6, DPP10, and KCNE2—that regulate its trafficking, surface expression, and gating kinetics through mechanisms including KChIP palmitoylation-dependent membrane targeting and Ca²⁺-dependent modulation of inactivation states [PMID:12135940, PMID:12006572, PMID:15890703, PMID:16738002]. Channel activity is further regulated by CaMKII phosphorylation at S550, PKCα phosphorylation at isoform-specific sites, Ang II–AT1R signaling through NADPH oxidase/p38 MAPK/AUF1-mediated mRNA destabilization, NRSF-mediated epigenetic silencing, thyroid hormone receptors, and direct physical interaction with AT1R and SEMA3A; additionally, Kv4.3 sequesters inactive CaMKII at the membrane, suppressing pathological CaMKII autophosphorylation [PMID:15456698, PMID:19675305, PMID:18789946, PMID:20006971, PMID:19171649, PMID:15342638, PMID:24963029, PMID:21148163]. Loss-of-function KCND3 mutations cause spinocerebellar ataxia type 19/22 (SCA19/22) through dominant-negative ER retention and impaired channel trafficking, while gain-of-function mutations cause Brugada syndrome via enhanced Ito [PMID:23280837, PMID:25854634, PMID:21349352]."},"prefetch_data":{"uniprot":{"accession":"Q9UK17","full_name":"A-type voltage-gated potassium channel KCND3","aliases":["Potassium voltage-gated channel subfamily D member 3","Voltage-gated potassium channel subunit Kv4.3"],"length_aa":655,"mass_kda":73.5,"function":"Pore-forming (alpha) subunit of voltage-gated A-type potassium channels that mediates transmembrane potassium transport in excitable membranes, in brain and heart (PubMed:10200233, PubMed:17187064, PubMed:21349352, PubMed:22457051, PubMed:23280837, PubMed:23280838, PubMed:34997220, PubMed:9843794). In cardiomyocytes, may generate the transient outward potassium current I(To) (By similarity). In neurons, may conduct the transient subthreshold somatodendritic A-type potassium current (ISA) (By similarity). Kinetics properties are characterized by fast activation at subthreshold membrane potentials, rapid inactivation, and quick recovery from inactivation (PubMed:10200233, PubMed:17187064, PubMed:21349352, PubMed:22457051, PubMed:23280837, PubMed:23280838, PubMed:34997220, PubMed:9843794). Channel properties are modulated by interactions with regulatory subunits (PubMed:17187064, PubMed:34997220). Interaction with the regulatory subunits KCNIP1 or KCNIP2 modulates the channel gating kinetics namely channel activation and inactivation kinetics and rate of recovery from inactivation (PubMed:17187064, PubMed:34997220). Likewise, interaction with DPP6 modulates the channel gating kinetics namely channel activation and inactivation kinetics (PubMed:34997220)","subcellular_location":"Cell membrane; Cell membrane, sarcolemma; Cell projection, dendrite","url":"https://www.uniprot.org/uniprotkb/Q9UK17/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/KCND3","classification":"Not Classified","n_dependent_lines":71,"n_total_lines":1208,"dependency_fraction":0.058774834437086095},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/KCND3","total_profiled":1310},"omim":[{"mim_id":"616399","title":"BRUGADA SYNDROME 9; BRGDA9","url":"https://www.omim.org/entry/616399"},{"mim_id":"608182","title":"POTASSIUM CHANNEL-INTERACTING PROTEIN 4","url":"https://www.omim.org/entry/608182"},{"mim_id":"607346","title":"SPINOCEREBELLAR ATAXIA 19; SCA19","url":"https://www.omim.org/entry/607346"},{"mim_id":"605411","title":"POTASSIUM VOLTAGE-GATED CHANNEL, SHAL-RELATED SUBFAMILY, MEMBER 3; KCND3","url":"https://www.omim.org/entry/605411"},{"mim_id":"605410","title":"POTASSIUM VOLTAGE-GATED CHANNEL, SHAL-RELATED SUBFAMILY, MEMBER 2; KCND2","url":"https://www.omim.org/entry/605410"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":28.5}],"url":"https://www.proteinatlas.org/search/KCND3"},"hgnc":{"alias_symbol":["Kv4.3","KSHIVB"],"prev_symbol":["SCA22","SCA19"]},"alphafold":{"accession":"Q9UK17","domains":[{"cath_id":"3.30.710.10","chopping":"40-155","consensus_level":"high","plddt":89.7384,"start":40,"end":155},{"cath_id":"1.20.120.350","chopping":"175-303","consensus_level":"high","plddt":86.4995,"start":175,"end":303},{"cath_id":"1.10.287.70","chopping":"311-418","consensus_level":"high","plddt":91.2797,"start":311,"end":418}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UK17","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UK17-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UK17-F1-predicted_aligned_error_v6.png","plddt_mean":70.44},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=KCND3","jax_strain_url":"https://www.jax.org/strain/search?query=KCND3"},"sequence":{"accession":"Q9UK17","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9UK17.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9UK17/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UK17"}},"corpus_meta":[{"pmid":"8831489","id":"PMC_8831489","title":"Role of the Kv4.3 K+ channel in ventricular muscle. A molecular correlate for the transient outward current.","date":"1996","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/8831489","citation_count":388,"is_preprint":false},{"pmid":"9760292","id":"PMC_9760292","title":"Molecular basis of transient outward potassium current downregulation in human heart failure: a decrease in Kv4.3 mRNA correlates with a reduction in current density.","date":"1998","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/9760292","citation_count":321,"is_preprint":false},{"pmid":"21349352","id":"PMC_21349352","title":"Transient outward current (I(to)) gain-of-function mutations in the KCND3-encoded Kv4.3 potassium channel and Brugada syndrome.","date":"2011","source":"Heart rhythm","url":"https://pubmed.ncbi.nlm.nih.gov/21349352","citation_count":185,"is_preprint":false},{"pmid":"23280837","id":"PMC_23280837","title":"Mutations in KCND3 cause spinocerebellar ataxia type 22.","date":"2012","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/23280837","citation_count":126,"is_preprint":false},{"pmid":"12006572","id":"PMC_12006572","title":"Palmitoylation of KChIP splicing variants is required for efficient cell surface expression of Kv4.3 channels.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12006572","citation_count":115,"is_preprint":false},{"pmid":"23280838","id":"PMC_23280838","title":"Mutations in potassium channel kcnd3 cause spinocerebellar ataxia type 19.","date":"2012","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/23280838","citation_count":113,"is_preprint":false},{"pmid":"9450548","id":"PMC_9450548","title":"Molecular cloning and tissue distribution of an alternatively spliced variant of an A-type K+ channel alpha-subunit, Kv4.3 in the rat.","date":"1997","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/9450548","citation_count":101,"is_preprint":false},{"pmid":"12135940","id":"PMC_12135940","title":"Regulation of Kv4.3 current by KChIP2 splice variants: a component of native cardiac I(to)?","date":"2002","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/12135940","citation_count":101,"is_preprint":false},{"pmid":"15890703","id":"PMC_15890703","title":"Expression and function of dipeptidyl-aminopeptidase-like protein 6 as a putative beta-subunit of human cardiac transient outward current encoded by Kv4.3.","date":"2005","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/15890703","citation_count":100,"is_preprint":false},{"pmid":"23400760","id":"PMC_23400760","title":"A novel KCND3 gain-of-function mutation associated with early-onset of persistent lone atrial fibrillation.","date":"2013","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/23400760","citation_count":98,"is_preprint":false},{"pmid":"10973847","id":"PMC_10973847","title":"Nicotine is a potent blocker of the cardiac A-type K(+) channels. Effects on cloned Kv4.3 channels and native transient outward current.","date":"2000","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/10973847","citation_count":96,"is_preprint":false},{"pmid":"9314834","id":"PMC_9314834","title":"Decreased expression of Kv4.2 and novel Kv4.3 K+ channel subunit mRNAs in ventricles of renovascular hypertensive rats.","date":"1997","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/9314834","citation_count":90,"is_preprint":false},{"pmid":"10330244","id":"PMC_10330244","title":"Regional contributions of Kv1.4, Kv4.2, and Kv4.3 to transient outward K+ current in rat ventricle.","date":"1999","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/10330244","citation_count":88,"is_preprint":false},{"pmid":"20006971","id":"PMC_20006971","title":"Neuron-restrictive silencer factor causes epigenetic silencing of Kv4.3 gene after peripheral nerve injury.","date":"2009","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/20006971","citation_count":86,"is_preprint":false},{"pmid":"10868735","id":"PMC_10868735","title":"Molecular remodeling of Kv4.3 potassium channels in human atrial fibrillation.","date":"2000","source":"Journal of cardiovascular electrophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/10868735","citation_count":81,"is_preprint":false},{"pmid":"11087728","id":"PMC_11087728","title":"Kvbeta subunits increase expression of Kv4.3 channels by interacting with their C termini.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11087728","citation_count":80,"is_preprint":false},{"pmid":"17122053","id":"PMC_17122053","title":"Differential expression of I(A) channel subunits Kv4.2 and Kv4.3 in mouse visual cortical neurons and synapses.","date":"2006","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/17122053","citation_count":69,"is_preprint":false},{"pmid":"15456698","id":"PMC_15456698","title":"Regulation of Kv4.3 currents by Ca2+/calmodulin-dependent protein kinase II.","date":"2004","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/15456698","citation_count":67,"is_preprint":false},{"pmid":"11249870","id":"PMC_11249870","title":"Independent regulation of cardiac Kv4.3 potassium channel expression by angiotensin II and phenylephrine.","date":"2001","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/11249870","citation_count":66,"is_preprint":false},{"pmid":"12433945","id":"PMC_12433945","title":"Elucidating KChIP effects on Kv4.3 inactivation and recovery kinetics with a minimal KChIP2 isoform.","date":"2002","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12433945","citation_count":65,"is_preprint":false},{"pmid":"16556864","id":"PMC_16556864","title":"Angiotensin II and stretch activate NADPH oxidase to destabilize cardiac Kv4.3 channel mRNA.","date":"2006","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/16556864","citation_count":64,"is_preprint":false},{"pmid":"10772652","id":"PMC_10772652","title":"Molecular dissection of cardiac repolarization by in vivo Kv4.3 gene transfer.","date":"2000","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/10772652","citation_count":62,"is_preprint":false},{"pmid":"17314290","id":"PMC_17314290","title":"Kv4.3-mediated A-type K+ currents underlie rhythmic activity in hippocampal interneurons.","date":"2007","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/17314290","citation_count":62,"is_preprint":false},{"pmid":"12764052","id":"PMC_12764052","title":"A novel autosomal dominant spinocerebellar ataxia (SCA22) linked to chromosome 1p21-q23.","date":"2003","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/12764052","citation_count":60,"is_preprint":false},{"pmid":"22457051","id":"PMC_22457051","title":"Novel mutations in the KCND3-encoded Kv4.3 K+ channel associated with autopsy-negative sudden unexplained death.","date":"2012","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/22457051","citation_count":59,"is_preprint":false},{"pmid":"14724186","id":"PMC_14724186","title":"Regulation of Kv4.3 voltage-dependent gating kinetics by KChIP2 isoforms.","date":"2004","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/14724186","citation_count":59,"is_preprint":false},{"pmid":"15342638","id":"PMC_15342638","title":"Angiotensin receptor type 1 forms a complex with the transient outward potassium channel Kv4.3 and regulates its gating properties and intracellular localization.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15342638","citation_count":59,"is_preprint":false},{"pmid":"20371829","id":"PMC_20371829","title":"Molecular dissection of I(A) in cortical pyramidal neurons reveals three distinct components encoded by Kv4.2, Kv4.3, and Kv1.4 alpha-subunits.","date":"2010","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/20371829","citation_count":57,"is_preprint":false},{"pmid":"9001401","id":"PMC_9001401","title":"Cloning, expression and CNS distribution of Kv4.3, an A-type K+ channel alpha subunit.","date":"1997","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/9001401","citation_count":55,"is_preprint":false},{"pmid":"26189493","id":"PMC_26189493","title":"First de novo KCND3 mutation causes severe Kv4.3 channel dysfunction leading to early onset cerebellar ataxia, intellectual disability, oral apraxia and epilepsy.","date":"2015","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26189493","citation_count":51,"is_preprint":false},{"pmid":"12384780","id":"PMC_12384780","title":"Identification of a novel SCA locus ( SCA19) in a Dutch autosomal dominant cerebellar ataxia family on chromosome region 1p21-q21.","date":"2002","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12384780","citation_count":50,"is_preprint":false},{"pmid":"20044444","id":"PMC_20044444","title":"Downregulated Kv4.3 expression in the RVLM as a potential mechanism for sympathoexcitation in rats with chronic heart failure.","date":"2009","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/20044444","citation_count":50,"is_preprint":false},{"pmid":"15557376","id":"PMC_15557376","title":"In vivo cardiac gene transfer of Kv4.3 abrogates the hypertrophic response in rats after aortic stenosis.","date":"2004","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/15557376","citation_count":49,"is_preprint":false},{"pmid":"16648177","id":"PMC_16648177","title":"Differential modulation of Kv4.2 and Kv4.3 channels by calmodulin-dependent protein kinase II in rat cardiac myocytes.","date":"2006","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16648177","citation_count":49,"is_preprint":false},{"pmid":"24963029","id":"PMC_24963029","title":"Characterization of SEMA3A-encoded semaphorin as a naturally occurring Kv4.3 protein inhibitor and its contribution to Brugada syndrome.","date":"2014","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/24963029","citation_count":46,"is_preprint":false},{"pmid":"18045613","id":"PMC_18045613","title":"Kv4.3 is not required for the generation of functional Ito,f channels in adult mouse ventricles.","date":"2007","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/18045613","citation_count":43,"is_preprint":false},{"pmid":"18678642","id":"PMC_18678642","title":"Nitric oxide inhibits Kv4.3 and human cardiac transient outward potassium current (Ito1).","date":"2008","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/18678642","citation_count":41,"is_preprint":false},{"pmid":"10325966","id":"PMC_10325966","title":"Characterisation of Kv4.3 in HEK293 cells: comparison with the rat ventricular transient outward potassium current.","date":"1999","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/10325966","citation_count":39,"is_preprint":false},{"pmid":"31173922","id":"PMC_31173922","title":"A de novo gain-of-function KCND3 mutation in early repolarization syndrome.","date":"2019","source":"Heart rhythm","url":"https://pubmed.ncbi.nlm.nih.gov/31173922","citation_count":36,"is_preprint":false},{"pmid":"30776697","id":"PMC_30776697","title":"Gene mutational analysis in a cohort of Chinese children with unexplained epilepsy: Identification of a new KCND3 phenotype and novel genes causing Dravet syndrome.","date":"2019","source":"Seizure","url":"https://pubmed.ncbi.nlm.nih.gov/30776697","citation_count":34,"is_preprint":false},{"pmid":"29313436","id":"PMC_29313436","title":"Down-regulation of Kv4.3 channels and a-type K+ currents in V2 trigeminal ganglion neurons of rats following oxaliplatin treatment.","date":"2018","source":"Molecular pain","url":"https://pubmed.ncbi.nlm.nih.gov/29313436","citation_count":34,"is_preprint":false},{"pmid":"10200233","id":"PMC_10200233","title":"Cloning and expression of the human kv4.3 potassium channel.","date":"1999","source":"Journal of neurophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/10200233","citation_count":34,"is_preprint":false},{"pmid":"10325968","id":"PMC_10325968","title":"Functional expression of an inactivating potassium channel (Kv4.3) in a mammalian cell line.","date":"1999","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/10325968","citation_count":34,"is_preprint":false},{"pmid":"12788813","id":"PMC_12788813","title":"Dihydropyridine Ca2+ channel antagonists and agonists block Kv4.2, Kv4.3 and Kv1.4 K+ channels expressed in HEK293 cells.","date":"2003","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12788813","citation_count":33,"is_preprint":false},{"pmid":"19616555","id":"PMC_19616555","title":"Endocannabinoids and cannabinoid analogues block human cardiac Kv4.3 channels in a receptor-independent manner.","date":"2009","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/19616555","citation_count":32,"is_preprint":false},{"pmid":"12911756","id":"PMC_12911756","title":"Contrasting expression of Kv4.3, an A-type K+ channel, in migrating Purkinje cells and other post-migratory cerebellar neurons.","date":"2003","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/12911756","citation_count":32,"is_preprint":false},{"pmid":"16738002","id":"PMC_16738002","title":"DPP10 is an inactivation modulatory protein of Kv4.3 and Kv1.4.","date":"2006","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16738002","citation_count":31,"is_preprint":false},{"pmid":"12150935","id":"PMC_12150935","title":"Kinetic properties of Kv4.3 and their modulation by KChIP2b.","date":"2002","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/12150935","citation_count":30,"is_preprint":false},{"pmid":"10433502","id":"PMC_10433502","title":"Blockade by N-3 polyunsaturated fatty acid of the Kv4.3 current stably expressed in Chinese hamster ovary cells.","date":"1999","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/10433502","citation_count":29,"is_preprint":false},{"pmid":"30634540","id":"PMC_30634540","title":"Expression, Cellular and Subcellular Localisation of Kv4.2 and Kv4.3 Channels in the Rodent Hippocampus.","date":"2019","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30634540","citation_count":29,"is_preprint":false},{"pmid":"21148163","id":"PMC_21148163","title":"Dynamic Kv4.3-CaMKII unit in heart: an intrinsic negative regulator for CaMKII activation.","date":"2010","source":"European heart journal","url":"https://pubmed.ncbi.nlm.nih.gov/21148163","citation_count":28,"is_preprint":false},{"pmid":"25228688","id":"PMC_25228688","title":"Modulation of the voltage-gated potassium channel (Kv4.3) and the auxiliary protein (KChIP3) interactions by the current activator NS5806.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25228688","citation_count":28,"is_preprint":false},{"pmid":"19109250","id":"PMC_19109250","title":"Structural Insights into KChIP4a Modulation of Kv4.3 Inactivation.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19109250","citation_count":26,"is_preprint":false},{"pmid":"21232039","id":"PMC_21232039","title":"Rosiglitazone inhibits Kv4.3 potassium channels by open-channel block and acceleration of closed-state inactivation.","date":"2011","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/21232039","citation_count":26,"is_preprint":false},{"pmid":"15980874","id":"PMC_15980874","title":"Spironolactone and its main metabolite canrenoic acid block hKv1.5, Kv4.3 and Kv7.1 + minK channels.","date":"2005","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15980874","citation_count":26,"is_preprint":false},{"pmid":"20483361","id":"PMC_20483361","title":"High-mobility group box 1 (HMGB1) downregulates cardiac transient outward potassium current (Ito) through downregulation of Kv4.2 and Kv4.3 channel transcripts and proteins.","date":"2010","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/20483361","citation_count":26,"is_preprint":false},{"pmid":"25854634","id":"PMC_25854634","title":"Spinocerebellar ataxia type 19/22 mutations alter heterocomplex Kv4.3 channel function and gating in a dominant manner.","date":"2015","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/25854634","citation_count":25,"is_preprint":false},{"pmid":"20858500","id":"PMC_20858500","title":"Celecoxib blocks cardiac Kv1.5, Kv4.3 and Kv7.1 (KCNQ1) channels: effects on cardiac action potentials.","date":"2010","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/20858500","citation_count":25,"is_preprint":false},{"pmid":"12172648","id":"PMC_12172648","title":"External pore collapse as an inactivation mechanism for Kv4.3 K+ channels.","date":"2002","source":"The Journal of membrane biology","url":"https://pubmed.ncbi.nlm.nih.gov/12172648","citation_count":25,"is_preprint":false},{"pmid":"33472822","id":"PMC_33472822","title":"Kv4.3 Channel Dysfunction Contributes to Trigeminal Neuropathic Pain Manifested with Orofacial Cold Hypersensitivity in Rats.","date":"2021","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/33472822","citation_count":25,"is_preprint":false},{"pmid":"28947073","id":"PMC_28947073","title":"Expanding the phenotype of SCA19/22: Parkinsonism, cognitive impairment and epilepsy.","date":"2017","source":"Parkinsonism & related disorders","url":"https://pubmed.ncbi.nlm.nih.gov/28947073","citation_count":24,"is_preprint":false},{"pmid":"20042375","id":"PMC_20042375","title":"KCNE2 modulation of Kv4.3 current and its potential role in fatal rhythm disorders.","date":"2009","source":"Heart rhythm","url":"https://pubmed.ncbi.nlm.nih.gov/20042375","citation_count":24,"is_preprint":false},{"pmid":"15537499","id":"PMC_15537499","title":"Diltiazem inhibits hKv1.5 and Kv4.3 currents at therapeutic concentrations.","date":"2004","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/15537499","citation_count":23,"is_preprint":false},{"pmid":"18536731","id":"PMC_18536731","title":"Effects of MiRP1 and DPP6 beta-subunits on the blockade induced by flecainide of Kv4.3/KChIP2 channels.","date":"2008","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/18536731","citation_count":23,"is_preprint":false},{"pmid":"32823520","id":"PMC_32823520","title":"KCND3-Related Neurological Disorders: From Old to Emerging Clinical Phenotypes.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32823520","citation_count":23,"is_preprint":false},{"pmid":"19357248","id":"PMC_19357248","title":"S3b amino acid substitutions and ancillary subunits alter the affinity of Heteropoda venatoria toxin 2 for Kv4.3.","date":"2009","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/19357248","citation_count":23,"is_preprint":false},{"pmid":"22023388","id":"PMC_22023388","title":"Large T-antigen up-regulates Kv4.3 K⁺ channels through Sp1, and Kv4.3 K⁺ channels contribute to cell apoptosis and necrosis through activation of calcium/calmodulin-dependent protein kinase II.","date":"2012","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/22023388","citation_count":23,"is_preprint":false},{"pmid":"24762397","id":"PMC_24762397","title":"The potential role of Kv4.3 K+ channel in heart hypertrophy.","date":"2014","source":"Channels (Austin, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/24762397","citation_count":22,"is_preprint":false},{"pmid":"17312186","id":"PMC_17312186","title":"Open channel block of A-type, kv4.3, and delayed rectifier K+ channels, Kv1.3 and Kv3.1, by sibutramine.","date":"2007","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/17312186","citation_count":22,"is_preprint":false},{"pmid":"15895560","id":"PMC_15895560","title":"Clinical, psychological, and genetic characteristics of spinocerebellar ataxia type 19 (SCA19).","date":"2005","source":"Cerebellum (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/15895560","citation_count":21,"is_preprint":false},{"pmid":"14521958","id":"PMC_14521958","title":"Differential inhibition of transient outward currents of Kv1.4 and Kv4.3 by endothelin.","date":"2003","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/14521958","citation_count":21,"is_preprint":false},{"pmid":"16815868","id":"PMC_16815868","title":"Interaction of riluzole with the closed inactivated state of Kv4.3 channels.","date":"2006","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/16815868","citation_count":21,"is_preprint":false},{"pmid":"21129448","id":"PMC_21129448","title":"KChIP1 modulation of Kv4.3-mediated A-type K(+) currents and repetitive firing in hippocampal interneurons.","date":"2010","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/21129448","citation_count":20,"is_preprint":false},{"pmid":"23832378","id":"PMC_23832378","title":"Inhibition of cardiac Kv1.5 and Kv4.3 potassium channels by the class Ia anti-arrhythmic ajmaline: mode of action.","date":"2013","source":"Naunyn-Schmiedeberg's archives of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/23832378","citation_count":20,"is_preprint":false},{"pmid":"31293010","id":"PMC_31293010","title":"Novel SCA19/22-associated KCND3 mutations disrupt human KV 4.3 protein biosynthesis and channel gating.","date":"2019","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/31293010","citation_count":19,"is_preprint":false},{"pmid":"11270617","id":"PMC_11270617","title":"Regional expression of the splice variants of Kv4.3 in rat brain and effects of C-terminus deletion on expressed K+ currents.","date":"2001","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/11270617","citation_count":19,"is_preprint":false},{"pmid":"18401705","id":"PMC_18401705","title":"Enhanced trafficking of tetrameric Kv4.3 channels by KChIP1 clamping.","date":"2008","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/18401705","citation_count":18,"is_preprint":false},{"pmid":"28895081","id":"PMC_28895081","title":"Novel De Novo KCND3 Mutation in a Japanese Patient with Intellectual Disability, Cerebellar Ataxia, Myoclonus, and Dystonia.","date":"2018","source":"Cerebellum (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/28895081","citation_count":17,"is_preprint":false},{"pmid":"21148405","id":"PMC_21148405","title":"Inhibition of Kv4.3 by genistein via a tyrosine phosphorylation-independent mechanism.","date":"2010","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/21148405","citation_count":17,"is_preprint":false},{"pmid":"18789946","id":"PMC_18789946","title":"AUF1 is upregulated by angiotensin II to destabilize cardiac Kv4.3 channel mRNA.","date":"2008","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/18789946","citation_count":17,"is_preprint":false},{"pmid":"31600170","id":"PMC_31600170","title":"KCND3 potassium channel gene variant confers susceptibility to electrocardiographic early repolarization pattern.","date":"2019","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/31600170","citation_count":16,"is_preprint":false},{"pmid":"29383177","id":"PMC_29383177","title":"A novel KCND3 mutation associated with early-onset lone atrial fibrillation.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/29383177","citation_count":16,"is_preprint":false},{"pmid":"26721612","id":"PMC_26721612","title":"Role of Kv4.3 in Vibration-Induced Muscle Pain in the Rat.","date":"2015","source":"The journal of pain","url":"https://pubmed.ncbi.nlm.nih.gov/26721612","citation_count":16,"is_preprint":false},{"pmid":"10942109","id":"PMC_10942109","title":"Genomic organisation and chromosomal localisation of two members of the KCND ion channel family, KCND2 and KCND3.","date":"2000","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10942109","citation_count":15,"is_preprint":false},{"pmid":"12875427","id":"PMC_12875427","title":"Extracellular acidosis modulates drug block of Kv4.3 currents by flecainide and quinidine.","date":"2003","source":"Journal of cardiovascular electrophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/12875427","citation_count":15,"is_preprint":false},{"pmid":"23747723","id":"PMC_23747723","title":"Bone morphogenetic protein-4 contributes to the down-regulation of Kv4.3 K+ channels in pathological cardiac hypertrophy.","date":"2013","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/23747723","citation_count":15,"is_preprint":false},{"pmid":"26374734","id":"PMC_26374734","title":"Analysis of SCA8, SCA10, SCA12, SCA17 and SCA19 in patients with unknown spinocerebellar ataxia: a Thai multicentre study.","date":"2015","source":"BMC neurology","url":"https://pubmed.ncbi.nlm.nih.gov/26374734","citation_count":14,"is_preprint":false},{"pmid":"34248630","id":"PMC_34248630","title":"MiR-27a-3p/Hoxa10 Axis Regulates Angiotensin II-Induced Cardiomyocyte Hypertrophy by Targeting Kv4.3 Expression.","date":"2021","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/34248630","citation_count":14,"is_preprint":false},{"pmid":"34361012","id":"PMC_34361012","title":"Rare Gain-of-Function KCND3 Variant Associated with Cerebellar Ataxia, Parkinsonism, Cognitive Dysfunction, and Brain Iron Accumulation.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34361012","citation_count":14,"is_preprint":false},{"pmid":"26592512","id":"PMC_26592512","title":"Effects of neferine on Kv4.3 channels expressed in HEK293 cells and ex vivo electrophysiology of rabbit hearts.","date":"2015","source":"Acta pharmacologica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/26592512","citation_count":14,"is_preprint":false},{"pmid":"28544933","id":"PMC_28544933","title":"Cardiotoxic effect of levofloxacin and ciprofloxacin in rats with/without acute myocardial infarction: Impact on cardiac rhythm and cardiac expression of Kv4.3, Kv1.2 and Nav1.5 channels.","date":"2017","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/28544933","citation_count":14,"is_preprint":false},{"pmid":"35861988","id":"PMC_35861988","title":"Acacetin, a Potent Transient Outward Current Blocker, May Be a Novel Therapeutic for KCND3-Encoded Kv4.3 Gain-of-Function-Associated J-Wave Syndromes.","date":"2022","source":"Circulation. Genomic and precision medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35861988","citation_count":13,"is_preprint":false},{"pmid":"22618310","id":"PMC_22618310","title":"Duloxetine blocks cloned Kv4.3 potassium channels.","date":"2012","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/22618310","citation_count":13,"is_preprint":false},{"pmid":"32490811","id":"PMC_32490811","title":"Functional specification of CCK+ interneurons by alternative isoforms of Kv4.3 auxiliary subunits.","date":"2020","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/32490811","citation_count":13,"is_preprint":false},{"pmid":"21803046","id":"PMC_21803046","title":"Central role of PKCα in isoenzyme-selective regulation of cardiac transient outward current Ito and Kv4.3 channels.","date":"2011","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/21803046","citation_count":13,"is_preprint":false},{"pmid":"22192593","id":"PMC_22192593","title":"Block of cloned Kv4.3 potassium channels by dapoxetine.","date":"2011","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/22192593","citation_count":13,"is_preprint":false},{"pmid":"26016905","id":"PMC_26016905","title":"Two novel Brugada syndrome-associated mutations increase KV4.3 membrane expression and function.","date":"2015","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26016905","citation_count":13,"is_preprint":false},{"pmid":"19675305","id":"PMC_19675305","title":"Closed-state inactivation in Kv4.3 isoforms is differentially modulated by protein kinase C.","date":"2009","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/19675305","citation_count":13,"is_preprint":false},{"pmid":"19171649","id":"PMC_19171649","title":"Divergent regulation of cardiac KCND3 potassium channel expression by the thyroid hormone receptors alpha1 and beta1.","date":"2009","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/19171649","citation_count":12,"is_preprint":false},{"pmid":"26196737","id":"PMC_26196737","title":"Kv4.3-Encoded Fast Transient Outward Current Is Presented in Kv4.2 Knockout Mouse Cardiomyocytes.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26196737","citation_count":12,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":56069,"output_tokens":10016,"usd":0.159223},"stage2":{"model":"claude-opus-4-6","input_tokens":13985,"output_tokens":4599,"usd":0.27735},"total_usd":0.436573,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"Kv4.3 encodes a rapidly inactivating A-type K+ current (transient outward current, Ito) when expressed in heterologous systems, with biophysical and pharmacological properties matching native canine and human ventricular Ito.\",\n      \"method\": \"Heterologous expression and electrophysiology (whole-cell patch clamp) in Xenopus oocytes and cell lines\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — functional reconstitution in heterologous system, replicated across multiple species and labs\",\n      \"pmids\": [\"8831489\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Kv4.3 exists as alternatively spliced isoforms (short and long, differing by a 19-amino acid insertion in the C-terminal intracellular region); the long isoform is predominant in rat heart and lung, while both isoforms produce functional A-type K+ currents.\",\n      \"method\": \"RT-PCR cloning and functional expression in HEK293 cells with whole-cell patch clamp\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — molecular cloning plus functional electrophysiological characterization\",\n      \"pmids\": [\"9450548\", \"9314834\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Kv4.3 is expressed in rat hippocampus and multiple CNS regions and produces an A-type K+ current when expressed in Xenopus oocytes, consistent with a role in controlling subthreshold A-currents and neuronal excitability.\",\n      \"method\": \"cDNA cloning, functional expression in Xenopus oocytes, in situ hybridization\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution in oocytes plus regional expression mapping\",\n      \"pmids\": [\"9001401\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"KChIP2 auxiliary subunits associate with Kv4.3, increase current density, slow current decay in a Ca2+-dependent manner, and hasten recovery from inactivation; a steep transmural gradient of KChIP2 mRNA (but not protein) exists in human/canine ventricle.\",\n      \"method\": \"Heterologous co-expression, whole-cell patch clamp, kinetic RT-PCR, Western blot, immunocytochemistry\",\n      \"journal\": \"Circulation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods, replicated across labs\",\n      \"pmids\": [\"12135940\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Kv4.3 associates with Kvβ2 subunits in brain; Kvβ1 or Kvβ2 co-expression increases Kv4.3 current density and protein expression (by stabilizing the protein) without affecting channel gating; this interaction requires the C-terminus but not N-terminus of Kv4.3.\",\n      \"method\": \"Co-immunoprecipitation, transfection/expression in heterologous cells, whole-cell patch clamp, protein stability assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP plus functional electrophysiology with domain-mapping mutagenesis\",\n      \"pmids\": [\"11087728\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Nicotine directly blocks Kv4.3 channels (IC50 ~40 nM) by both tonic and use-dependent block, reducing single-channel conductance, open probability, and open time, without altering activation kinetics; this effect is receptor-independent.\",\n      \"method\": \"Whole-cell and single-channel patch clamp in Xenopus oocytes and canine ventricular myocytes\",\n      \"journal\": \"Circulation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro functional assay at multiple levels (whole-cell and single-channel), with pharmacological controls\",\n      \"pmids\": [\"10973847\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"In vivo overexpression of Kv4.3 by adenoviral gene transfer in guinea pig myocytes produces robust Ito, depresses the plateau potential, and abbreviates action potential duration; dominant-negative Kv4.3-W362F suppresses Ito in rats, elevates plateau height, prolongs APD by ~30%, and prolongs QT interval.\",\n      \"method\": \"In vivo adenoviral gene transfer, whole-cell patch clamp, surface ECG recordings\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean loss- and gain-of-function in vivo with defined electrophysiological phenotype\",\n      \"pmids\": [\"10772652\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Angiotensin II (Ang II) downregulates Kv4.3 mRNA by destabilizing the transcript (via mRNA half-life reduction), while phenylephrine (PE) downregulates Kv4.3 mRNA via transcriptional repression of the Kv4.3 promoter; the two pathways act independently.\",\n      \"method\": \"RNase protection assays, mRNA turnover measurements, Kv4.3 promoter-reporter assays in neonatal rat cardiac myocytes, immunoblots\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal mechanistic approaches distinguishing transcriptional vs. post-transcriptional regulation\",\n      \"pmids\": [\"11249870\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"KChIP auxiliary subunits modulate Kv4.3 inactivation and recovery via distinct structural domains: the EF-hand modulates effects on inactivation but not recovery; Ca2+-independent effects on recovery are mediated through a short non-EF-hand stretch; closed-state inactivation is Ca2+-independent while open-state inactivation is Ca2+-dependent.\",\n      \"method\": \"Cloning of minimal KChIP2d isoform, heterologous expression in Xenopus oocytes, whole-cell patch clamp with mutagenesis\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — domain-specific mutagenesis plus functional electrophysiology\",\n      \"pmids\": [\"12433945\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Palmitoylation of KChIP2 isoforms at N-terminal cysteine residues is required for plasma membrane localization of KChIP2 and for efficient trafficking and increased surface expression of associated Kv4.3 channels; metabolic labeling confirmed palmitoylation at these cysteines.\",\n      \"method\": \"Metabolic labeling (palmitoylation assay), site-directed mutagenesis, confocal microscopy, whole-cell patch clamp\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — metabolic labeling plus mutagenesis with functional readout\",\n      \"pmids\": [\"12006572\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"KChIP2b modulates Kv4.3 gating via inner pore structure; mutation of inner pore residues V399I/V401I reveals that the inner pore is important for the modulatory effect of KChIP2b on inactivation kinetics; KChIP2b increases rate of recovery from inactivation of both WT and mutant channels.\",\n      \"method\": \"Site-directed mutagenesis, heterologous expression, whole-cell patch clamp\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis plus electrophysiology; single lab, single paper\",\n      \"pmids\": [\"12150935\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Kv4.3 exhibits a C-type (external pore collapse) inactivation mechanism; removal of external K+ destabilizes the conducting state by collapsing the selectivity filter pore, consistent with C-type inactivation.\",\n      \"method\": \"Whole-cell voltage clamp, manipulation of external K+ concentration, biophysical analysis\",\n      \"journal\": \"The Journal of membrane biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro biophysical assay; single lab, single paper\",\n      \"pmids\": [\"12172648\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"CaMKII directly phosphorylates Kv4.3 at residue S550A in the C-terminal region, slowing inactivation and accelerating recovery from inactivation; mutation S550A abolishes these CaMKII effects, establishing S550 as the CaMKII target site.\",\n      \"method\": \"Site-directed mutagenesis, intracellular dialysis of autophosphorylated CaMKII, whole-cell patch clamp\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro kinase assay with mutagenesis identifying specific phosphorylation site\",\n      \"pmids\": [\"15456698\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"KChIP2 isoforms modulate Kv4.3 gating by accelerating recovery from inactivation, slowing closed-state inactivation, and promoting open-state inactivation; Ca2+-dependent effects operate selectively through open-state inactivation, while closed-state inactivation transitions are Ca2+-independent.\",\n      \"method\": \"Xenopus oocyte expression, whole-cell patch clamp with detailed kinetic modeling\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — detailed kinetic analysis with mechanistic model\",\n      \"pmids\": [\"14724186\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Angiotensin receptor type 1 (AT1R) forms a physical complex with Kv4.3 and KChIP2 in canine ventricular cells and HEK293 cells; Ang II treatment causes co-internalization of Kv4.3 with AT1R and shifts the activation voltage threshold of remaining surface Kv4.3 channels to more positive values.\",\n      \"method\": \"Co-immunoprecipitation, FRET, fluorescence co-localization (ECFP/EYFP-tagged proteins), whole-cell patch clamp\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP plus FRET with functional electrophysiological phenotype\",\n      \"pmids\": [\"15342638\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"In vivo Kv4.3 gene transfer in rats with aortic stenosis restores Ito density, shortens action potential duration, and abrogates the hypertrophic response by reducing calcineurin and NFATc1 expression, placing Kv4.3 upstream of the calcineurin/NFAT hypertrophic pathway.\",\n      \"method\": \"In vivo adenoviral gene transfer, whole-cell patch clamp, Western blot, heart weight measurements\",\n      \"journal\": \"Circulation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo gene transfer with epistatic pathway placement via calcineurin/NFAT\",\n      \"pmids\": [\"15557376\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"DPPX (DPP6) acts as an additional beta-subunit of Kv4.3 in human heart; co-expression of DPPX with Kv4.3 and KChIP2a reconstitutes native human cardiac Ito kinetics (faster inactivation, more negative half-inactivation, delayed recovery compared to Kv4.3+KChIP2a alone).\",\n      \"method\": \"Quantitative RT-PCR, Western blot with DPPX-specific antibody, co-expression in CHO cells, whole-cell patch clamp\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — reconstitution of native current properties plus protein detection in human heart\",\n      \"pmids\": [\"15890703\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Ang II and mechanical stretch activate NADPH oxidase (via AT1 receptors, superoxide, and ASK1-p38 kinase signaling) to specifically destabilize Kv4.3 channel mRNA through sequences in the 3'-UTR, while Kv4.2 and Kv1.5 3'-UTRs are insensitive.\",\n      \"method\": \"Reporter construct assays with Kv4.3 3'-UTR, dominant-negative Rac, NADPH oxidase inhibitors, SOD/catalase overexpression, kinase inhibitors in neonatal rat cardiac myocytes\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple pharmacological and genetic perturbations with specific molecular readout\",\n      \"pmids\": [\"16556864\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"DPP10 modulates Kv4.3 inactivation by causing negative shifts in steady-state activation and inactivation and promoting closed-state inactivation, through its transmembrane and short cytoplasmic domain; DPP10 and KChIP2b have different primary effects (closed-state vs. open-state inactivation respectively).\",\n      \"method\": \"Heterologous co-expression, whole-cell patch clamp, truncation mutagenesis of DPP10\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — functional reconstitution with domain-mapping mutagenesis\",\n      \"pmids\": [\"16738002\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"CaMKII co-immunoprecipitates with Kv4.3 (but not Kv4.2) in rat cardiac myocytes without prior Ca2+ elevation; CaMKII phosphorylates Kv4.3 at baseline, slowing its inactivation; Kv4.3 acts as a molecular scaffold concentrating CaMKII at the membrane, enabling Ca2+-dependent modulation of associated Kv4.2 channels.\",\n      \"method\": \"Co-immunoprecipitation, Western blot with phospho-specific antibodies, whole-cell patch clamp in myocytes and HEK cells\",\n      \"journal\": \"American journal of physiology. Heart and circulatory physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — co-IP with biochemical and electrophysiological validation\",\n      \"pmids\": [\"16648177\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Kv4.3 mediates A-type K+ currents in CA1 LM/RAD hippocampal interneurons and is required for subthreshold membrane potential oscillations; siRNA knockdown of Kv4.3 selectively impairs A-type K+ currents and MPOs in these interneurons.\",\n      \"method\": \"siRNA knockdown, whole-cell patch clamp, immunolabeling in hippocampal slices\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function siRNA with specific electrophysiological phenotype\",\n      \"pmids\": [\"17314290\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"AUF1 (ARE/poly-U binding/degradation factor 1) is upregulated by Ang II via AT1R-NADPH oxidase-p38 MAPK signaling; AUF1 binds to an AU-rich element (ARE) in the Kv4.3 3'-UTR to destabilize the channel mRNA; overexpression of AUF1 mimics and occludes the Ang II effect, and siRNA against AUF1 blocks it.\",\n      \"method\": \"Deletion and mutagenesis of 3'-UTR ARE, AUF1 overexpression and siRNA knockdown, RNA pulldown assays, reporter assays\",\n      \"journal\": \"Journal of molecular and cellular cardiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal approaches identifying specific mRNA-destabilizing mechanism\",\n      \"pmids\": [\"18789946\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"KCNE2 (MiRP1) co-assembles with Kv4.3 and reduces peak current density, slows inactivation, and shifts steady-state inactivation positively, making Kv4.3 more like native cardiac Ito; KCNE2 variants M54T and I57T cause gain-of-function by increasing current density.\",\n      \"method\": \"Heterologous co-expression in cell lines, whole-cell patch clamp\",\n      \"journal\": \"Heart rhythm\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional reconstitution; single lab, no structural validation\",\n      \"pmids\": [\"20042375\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"KChIP4a crystal structure at 3.0 Å resolution shows distinct N-terminal alpha-helices; competitive binding of the Kv4.3 N-terminal peptide to the hydrophobic groove of KChIP4a displaces the KChIP4a N-terminus, which acts as a slow inactivation gate suppressing Kv4.3 inactivation.\",\n      \"method\": \"X-ray crystallography, biochemical binding assays, electrophysiology, N-terminal peptide fusion experiments\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure plus biochemical and functional validation\",\n      \"pmids\": [\"19109250\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Nerve injury causes NRSF to bind the NRSE element in the Kv4.3 gene promoter in dorsal root ganglion neurons, leading to deacetylation of histone H4 at the NRSE (epigenetic silencing) and long-lasting Kv4.3 mRNA downregulation; NRSF antisense knockdown blocks this effect.\",\n      \"method\": \"ChIP assay for NRSF binding and histone acetylation, RT-PCR, antisense knockdown in vivo\",\n      \"journal\": \"Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP assay with antisense rescue establishing epigenetic mechanism\",\n      \"pmids\": [\"20006971\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Alanine scanning of the Kv4.3 S3b region identifies L275 and V276 as critical residues for interaction with HpTx2 (an ICK gating modifier toxin); KChIP2b stabilizes the closed state of Kv4.3, increasing HpTx2 affinity; the S3b hydrophobic character is the primary determinant of toxin binding.\",\n      \"method\": \"Site-directed mutagenesis, functional expression, concentration-response electrophysiology\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — systematic mutagenesis of binding site; single lab\",\n      \"pmids\": [\"19357248\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Thyroid hormone receptor alpha1 (TRα1) activates KCND3 transcription via a response element at -1651 bp, while TRβ1 suppresses KCND3 transcription via a different response element at -73 bp; both effects are ligand-dependent; TRα1 increases Ito and TRβ1 reduces Ito in cardiomyocytes.\",\n      \"method\": \"Adenoviral gene transfer, promoter-reporter constructs, mutagenesis of TR binding sites, whole-cell patch clamp in rat cardiomyocytes\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — promoter deletion and mutagenesis with functional electrophysiological readout\",\n      \"pmids\": [\"19171649\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Ang II downregulates Kv4.3 mRNA and protein in RVLM neurons via AT1R-ROS-p38 MAPK signaling, decreasing A-type K+ current and increasing neuronal excitability; this mechanism contributes to sympathoexcitation in chronic heart failure.\",\n      \"method\": \"GeneChip screening, RT-PCR, Western blot, whole-cell patch clamp in CATH.a neurons, microinjection in intact animals, kinase inhibitors\",\n      \"journal\": \"American journal of physiology. Heart and circulatory physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple methods in neuronal cell line; in vivo corroboration with microinjection\",\n      \"pmids\": [\"20044444\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Kv4.3 and inactive CaMKII form a complex at the cardiomyocyte membrane (shown by co-IP and FRET); Kv4.3 blocks CaMKII activation by binding to the calmodulin binding sites; dissociation of CaMKII from the Kv4.3-CaMKII complex releases these sites and leads to CaMKII autophosphorylation and L-type Ca2+ current facilitation. Kv4.3 overexpression reduces basal CaMKII autophosphorylation.\",\n      \"method\": \"Co-immunoprecipitation, FRET, L-type Ca2+ current recordings, Ca2+ chelation (BAPTA vs. EGTA), Kv4.3 overexpression in myocytes\",\n      \"journal\": \"European heart journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP plus FRET plus functional electrophysiological consequences\",\n      \"pmids\": [\"21148163\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Kv4.2, Kv4.3, and Kv1.4 alpha-subunits encode three distinct, separable components of the macroscopic IA current in mouse cortical pyramidal neurons, as determined by targeted gene deletion.\",\n      \"method\": \"Genetic knockout (Kv4.2-/-, Kv4.3-/-, double and compound knockouts), whole-cell patch clamp with pharmacological blockers\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic loss-of-function with specific electrophysiological phenotype\",\n      \"pmids\": [\"20371829\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"PKCα is the primary isoenzyme mediating PKC-dependent reduction of Kv4.3 current; conventional PKC activation reduces Kv4.3 current in a PKCα-dependent manner (blocked by PKCα siRNA and HBDDE), while novel PKC isoforms have no significant effect.\",\n      \"method\": \"Xenopus oocyte expression with double electrode voltage clamp, siRNA knockdown of PKC isoforms, pharmacological activators/inhibitors, patch clamp in rat cardiomyocytes\",\n      \"journal\": \"Journal of molecular and cellular cardiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — siRNA plus pharmacological isoenzyme-selective perturbation with functional readout\",\n      \"pmids\": [\"21803046\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Two KCND3 gain-of-function mutations (L450F and G600R) associated with Brugada syndrome increase peak Ito current density by 146% and 50%, respectively, when co-expressed with KChIP2 in HEK293 cells; simulation modeling shows that increased Ito causes loss of the action potential dome.\",\n      \"method\": \"Site-directed mutagenesis, co-expression with KChIP2, whole-cell patch clamp in HEK293 cells, Luo-Rudy AP simulation\",\n      \"journal\": \"Heart rhythm\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — functional reconstitution with mutagenesis and computational modeling\",\n      \"pmids\": [\"21349352\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"KCND3 loss-of-function mutations causing SCA19/22 (T352P, M373I, S390N, F227del, G345V, V338E, T377M) result in ER retention, protein instability, and absent or reduced K+ channel current; KChIP2 can rescue membrane localization and stability of some mutants but does not fully restore channel function.\",\n      \"method\": \"Whole exome sequencing, site-directed mutagenesis, heterologous expression in HeLa cells, immunofluorescence, patch-clamp electrophysiology, autopsy immunohistochemistry\",\n      \"journal\": \"Annals of neurology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — two independent studies with orthogonal methods, multiple mutations characterized\",\n      \"pmids\": [\"23280837\", \"23280838\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Large T-antigen upregulates Kv4.3 expression through increasing the transcription factor Sp1; Sp1 decoy oligonucleotides reduce Kv4.3 expression; Kv4.3 inhibition (via 4-AP or siRNA) induces cell apoptosis and necrosis through CaMKII activation (prevented by KN-93).\",\n      \"method\": \"Sp1 decoy oligonucleotides, Sp1 overexpression vector, Kv4.3 siRNA, pharmacological blockers, cell death assays, KN-93 rescue in HEK293/HEK293T cells\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple genetic and pharmacological perturbations; single lab\",\n      \"pmids\": [\"22023388\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Closed-state inactivation (CSI) of Kv4.3 isoforms is differentially regulated by PKC: PMA reduces CSI in Kv4.3-S but increases CSI in Kv4.3-L; mutation of T504 (a PKC site unique to the 19-amino acid insert of Kv4.3-L) to aspartate eliminates the PMA response, identifying T504 as the isoform-specific PKC phosphorylation site.\",\n      \"method\": \"Site-directed mutagenesis, Xenopus oocyte expression with double electrode voltage clamp, PMA and purified PKC treatment\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis identifying specific phosphorylation site with isoform-selective functional consequence\",\n      \"pmids\": [\"19675305\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"NS5806 binds to a hydrophobic site on the C-terminus of KChIP3 in a Ca2+-dependent manner (Kd 2-5 μM), increasing the affinity between KChIP3 and the N-terminus of Kv4.3 and decreasing the rate of their dissociation; Tyr-174 and Phe-218 on KChIP3 are required for this drug-induced enhancement.\",\n      \"method\": \"Fluorescence spectroscopy, isothermal titration calorimetry, docking simulations, site-directed mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — biophysical binding measurements plus mutagenesis identifying specific interface residues\",\n      \"pmids\": [\"25228688\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"SEMA3A (semaphorin 3A) selectively inhibits Kv4.3 (but not Nav1.5, Cav1.2, or Kv4.2) by directly binding to Kv4.3, reducing peak current density without altering surface protein expression; co-immunoprecipitation confirms physical interaction; disruption of a putative toxin-binding domain on Kv4.3 disrupts SEMA3A inhibition.\",\n      \"method\": \"Co-immunoprecipitation, whole-cell patch clamp in HEK293 cells and hiPSC-derived cardiomyocytes, domain disruption mutagenesis, perfusion experiments\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — co-IP plus domain mutagenesis plus functional electrophysiology in multiple systems\",\n      \"pmids\": [\"24963029\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"SCA19/22-mutant Kv4.3 subunits exert dominant negative effects on wild-type Kv4.3 trafficking and surface expression in the absence of KChIP2; KChIP2 co-expression rescues this dominant negative effect on trafficking; all tested mutants either suppress WT Kv4.3 current amplitude or alter gating in a dominant manner.\",\n      \"method\": \"Co-expression of mutant and WT Kv4.3, immunofluorescence for localization, whole-cell patch clamp\",\n      \"journal\": \"Cellular and molecular life sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple SCA mutations tested with rescue by KChIP2; dominant-negative mechanism established\",\n      \"pmids\": [\"25854634\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"A de novo KCND3 mutation (p.Arg293_Phe295dup) duplicating the RVF motif in the voltage-sensor domain causes a severe positive shift in voltage-dependence of gating and markedly reduced channel opening, correlating with a severe SCA19/22 phenotype with intellectual disability, epilepsy, and ataxia.\",\n      \"method\": \"Whole exome sequencing, immunocytochemistry, immunoblotting, patch clamp assays\",\n      \"journal\": \"BMC medical genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional characterization of de novo variant; single case/lab\",\n      \"pmids\": [\"26189493\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Novel SCA19/22-associated KCND3 mutations (C317Y, P375S, V338E, T377M) cause loss-of-function with enhanced protein degradation and defective membrane trafficking; co-expression of mutant subunits with WT KV4.3 demonstrates dominant-negative effects on protein biosynthesis and voltage-dependent gating.\",\n      \"method\": \"Targeted NGS, heterologous expression, electrophysiology, Western blot for protein stability, immunofluorescence for trafficking, co-expression with WT channel\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple mutations with orthogonal biochemical and functional readouts; dominant-negative mechanism directly demonstrated\",\n      \"pmids\": [\"31293010\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"KChIP1 co-expression modulates Kv4.3 A-type K+ currents in HEK293 cells (faster recovery, leftward activation shift, faster rise time, slower decay); in hippocampal LM/RAD interneurons, KChIP1 siRNA knockdown slows recovery from inactivation and increases firing frequency during sustained depolarization, indicating KChIP1 regulates Kv4.3-based interneuron excitability.\",\n      \"method\": \"HEK293 co-expression electrophysiology, siRNA knockdown in hippocampal slice cultures, whole-cell patch clamp\",\n      \"journal\": \"Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — siRNA knockdown in native neurons with defined excitability phenotype, corroborated by heterologous system\",\n      \"pmids\": [\"21129448\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Alternative isoforms of Kv4 auxiliary subunits (KChIP1 vs. KChIP4e and DPP6S) determine distinct firing phenotypes of CCK+ hippocampal interneurons by differentially modulating Kv4.3-mediated low-voltage-activated K+ currents, despite comparable Kv4.3 expression levels in both cell types.\",\n      \"method\": \"Patch clamp electrophysiology in hippocampal slices, immunohistochemistry, transcriptomic profiling, pharmacology\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal approaches linking specific auxiliary subunit isoforms to distinct electrophysiological phenotypes in native interneurons\",\n      \"pmids\": [\"32490811\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Downregulation of Kv4.3 in nociceptive trigeminal ganglion neurons after infraorbital nerve injury reduces IA currents and underlies cold hypersensitivity; pharmacological inhibition of Kv4.3 (phrixotoxin-2) recapitulates cold allodynia, while pharmacological potentiation of Kv4.3 alleviates it in ION-CCI rats.\",\n      \"method\": \"Immunostaining, patch-clamp of acutely dissociated TG neurons, orofacial operant behavioral testing, pharmacological manipulation in vivo\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function and gain-of-function pharmacological manipulation with defined behavioral and electrophysiological phenotypes\",\n      \"pmids\": [\"33472822\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"miR-27a-3p targets the 3'-UTR of Hoxa10, reducing Hoxa10 protein expression; Hoxa10 positively regulates Kv4.3 expression; miR-27a-3p inhibition or Hoxa10 overexpression alleviates Ang II-induced cardiomyocyte hypertrophy and restores Kv4.3 levels, establishing a miR-27a-3p/Hoxa10/Kv4.3 regulatory axis.\",\n      \"method\": \"Luciferase reporter assay, miRNA inhibitor transfection, Hoxa10 overexpression, Western blot, patch clamp\",\n      \"journal\": \"Frontiers in pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — luciferase assay plus rescue experiments; single lab\",\n      \"pmids\": [\"34248630\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"KCND3-encoded Kv4.3 is a voltage-gated K+ channel alpha-subunit that assembles with auxiliary subunits (KChIP1-4, Kvβ, DPPX/DPP6, DPP10, KCNE2/MiRP1) into macromolecular complexes at the plasma membrane to generate the fast transient outward K+ current (Ito) in heart and A-type K+ current (IA) in neurons; its trafficking, surface expression, and gating are regulated by KChIP palmitoylation, CaMKII phosphorylation at S550, PKCα phosphorylation at isoform-specific sites, Ang II-AT1R signaling through NADPH oxidase/p38 MAPK/AUF1-mediated mRNA destabilization, NRSF-mediated epigenetic silencing, thyroid hormone receptor isoforms, and physical interaction with AT1R and SEMA3A; in cardiomyocytes Kv4.3 sequesters inactive CaMKII, suppressing pathological CaMKII activation, while loss-of-function mutations cause SCA19/22 cerebellar ataxia via dominant-negative ER retention and gain-of-function mutations cause J-wave syndromes and arrhythmias via enhanced Ito.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"KCND3 encodes the Kv4.3 voltage-gated potassium channel α-subunit, which generates the fast transient outward K⁺ current (Ito) in cardiomyocytes and the A-type K⁺ current (IA) in neurons, thereby shaping action potential repolarization, neuronal excitability, and subthreshold membrane potential oscillations [PMID:8831489, PMID:10772652, PMID:17314290]. Kv4.3 assembles into macromolecular complexes with auxiliary subunits—KChIP1–4, Kvβ, DPPX/DPP6, DPP10, and KCNE2—that regulate its trafficking, surface expression, and gating kinetics through mechanisms including KChIP palmitoylation-dependent membrane targeting and Ca²⁺-dependent modulation of inactivation states [PMID:12135940, PMID:12006572, PMID:15890703, PMID:16738002]. Channel activity is further regulated by CaMKII phosphorylation at S550, PKCα phosphorylation at isoform-specific sites, Ang II–AT1R signaling through NADPH oxidase/p38 MAPK/AUF1-mediated mRNA destabilization, NRSF-mediated epigenetic silencing, thyroid hormone receptors, and direct physical interaction with AT1R and SEMA3A; additionally, Kv4.3 sequesters inactive CaMKII at the membrane, suppressing pathological CaMKII autophosphorylation [PMID:15456698, PMID:19675305, PMID:18789946, PMID:20006971, PMID:19171649, PMID:15342638, PMID:24963029, PMID:21148163]. Loss-of-function KCND3 mutations cause spinocerebellar ataxia type 19/22 (SCA19/22) through dominant-negative ER retention and impaired channel trafficking, while gain-of-function mutations cause Brugada syndrome via enhanced Ito [PMID:23280837, PMID:25854634, PMID:21349352].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Establishing KCND3 as the molecular identity of Ito resolved which gene encodes the fast transient outward K⁺ current in ventricular myocytes.\",\n      \"evidence\": \"Heterologous expression in Xenopus oocytes and cell lines reproduced biophysical and pharmacological properties of native canine/human ventricular Ito\",\n      \"pmids\": [\"8831489\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No auxiliary subunit contributions yet defined\", \"Native channel complex composition unknown\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Discovery of alternative splicing and CNS expression expanded Kv4.3 from a cardiac channel to a broadly expressed neuronal A-type K⁺ current generator.\",\n      \"evidence\": \"RT-PCR cloning identified short and long isoforms differing by 19 amino acids; in situ hybridization mapped expression in hippocampus and multiple CNS regions; both isoforms produced functional currents\",\n      \"pmids\": [\"9450548\", \"9314834\", \"9001401\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of the 19-aa insert unknown\", \"Relative contribution to neuronal IA vs. Kv4.2 not established\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Identification of KChIP and Kvβ auxiliary subunits as Kv4.3 partners explained how native Ito properties diverge from recombinant Kv4.3 alone and how the channel is stabilized and trafficked.\",\n      \"evidence\": \"Co-IP, co-expression electrophysiology, and protein stability assays showed KChIP2 increases current density in a Ca²⁺-dependent manner and Kvβ stabilizes Kv4.3 protein via C-terminal interaction\",\n      \"pmids\": [\"12135940\", \"11087728\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full stoichiometry of the native complex not determined\", \"KChIP transmural gradient mechanism not resolved\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"In vivo gain- and loss-of-function demonstrated that Kv4.3 is rate-limiting for action potential duration and QT interval, establishing its physiological necessity.\",\n      \"evidence\": \"Adenoviral Kv4.3 overexpression in guinea pig created Ito and shortened APD; dominant-negative Kv4.3-W362F in rat prolonged APD by ~30% and prolonged QT\",\n      \"pmids\": [\"10772652\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Long-term consequences of Kv4.3 manipulation on arrhythmia susceptibility not tested\", \"Compensatory remodeling of other K⁺ channels not excluded\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Mapping the KChIP–Kv4.3 gating interface and demonstrating palmitoylation-dependent trafficking resolved how auxiliary subunits control both channel biophysics and surface expression.\",\n      \"evidence\": \"EF-hand mutagenesis separated Ca²⁺-dependent open-state from Ca²⁺-independent closed-state inactivation modulation; metabolic labeling confirmed KChIP2 palmitoylation at N-terminal cysteines is required for plasma membrane targeting of the complex\",\n      \"pmids\": [\"12433945\", \"12006572\", \"12150935\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the palmitoyl transferase unknown\", \"Structural basis of KChIP-Kv4.3 interaction at atomic level not yet available\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Discovery of CaMKII phosphorylation at S550 and AT1R–Kv4.3 complex formation revealed that the channel is both a kinase substrate and a signaling scaffold.\",\n      \"evidence\": \"CaMKII dialysis slowed inactivation abolished by S550A mutation; co-IP and FRET showed AT1R physically associates with Kv4.3/KChIP2, and Ang II causes co-internalization\",\n      \"pmids\": [\"15456698\", \"15342638\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether S550 phosphorylation occurs tonically in vivo unresolved\", \"Structural basis of AT1R–Kv4.3 interaction unknown\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Kv4.3 gene transfer in pressure-overloaded hearts reversed hypertrophy by suppressing calcineurin/NFAT, placing Kv4.3 upstream of a major hypertrophic signaling pathway.\",\n      \"evidence\": \"Adenoviral Kv4.3 in aortic-banded rats restored Ito, shortened APD, and reduced calcineurin/NFATc1 expression and heart weight\",\n      \"pmids\": [\"15557376\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the anti-hypertrophic effect is purely electrophysiological or also involves CaMKII sequestration not dissected\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Identification of DPPX and DPP10 as additional auxiliary subunits completed the reconstitution of native Ito/IA kinetics and showed that distinct accessory proteins control closed-state versus open-state inactivation.\",\n      \"evidence\": \"DPPX + KChIP2a + Kv4.3 co-expression in CHO cells reconstituted native human cardiac Ito; DPP10 truncation mutagenesis showed its transmembrane domain promotes closed-state inactivation\",\n      \"pmids\": [\"15890703\", \"16738002\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative stoichiometry of DPPX vs. DPP10 in different tissues unknown\", \"Whether DPPX and KChIP compete or co-assemble simultaneously not fully resolved\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Delineation of the Ang II–NADPH oxidase–p38 MAPK–AUF1 axis targeting Kv4.3 3ʹ-UTR explained the post-transcriptional mechanism of Ito remodeling in hypertrophy and heart failure.\",\n      \"evidence\": \"Reporter constructs with Kv4.3 3ʹ-UTR, dominant-negative Rac, NADPH oxidase inhibitors, and AUF1 overexpression/siRNA showed specificity for Kv4.3 mRNA destabilization via an AU-rich element\",\n      \"pmids\": [\"16556864\", \"18789946\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether other ARE-binding proteins besides AUF1 contribute not excluded\", \"In vivo validation of AUF1 role in intact heart not performed\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"PKCα was identified as the specific conventional PKC isoform reducing Kv4.3 current, with T504 in the long-isoform 19-aa insert as the isoform-selective phosphorylation site controlling closed-state inactivation.\",\n      \"evidence\": \"PKCα siRNA and selective inhibitors blocked current reduction; T504D mutation in Kv4.3-L eliminated PMA response\",\n      \"pmids\": [\"21803046\", \"19675305\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PKCα and CaMKII phosphorylation interact at the channel level not tested\", \"In vivo relevance of T504 phosphorylation not demonstrated\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"NRSF-mediated epigenetic silencing of Kv4.3 after nerve injury explained persistent IA downregulation and neuropathic pain sensitization at a chromatin level.\",\n      \"evidence\": \"ChIP showed NRSF binding to NRSE in Kv4.3 promoter with H4 deacetylation in DRG neurons; NRSF antisense blocked Kv4.3 downregulation\",\n      \"pmids\": [\"20006971\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the HDAC recruited by NRSF at Kv4.3 locus unknown\", \"Whether this mechanism operates in cardiac remodeling not tested\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Demonstration that Kv4.3 sequesters inactive CaMKII at the membrane established a non-conducting signaling function: Kv4.3 loss releases CaMKII, enabling pathological autophosphorylation and L-type Ca²⁺ current facilitation.\",\n      \"evidence\": \"Co-IP and FRET confirmed Kv4.3–CaMKII complex; Kv4.3 overexpression reduced basal CaMKII autophosphorylation; CaMKII release enhanced ICa,L facilitation\",\n      \"pmids\": [\"21148163\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of CaMKII–Kv4.3 interaction not resolved\", \"Relative contribution of conducting vs. scaffolding function in disease not quantified\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identification of KCND3 loss-of-function mutations causing SCA19/22 via ER retention and dominant-negative suppression of wild-type channel trafficking established Kv4.3 as essential for cerebellar function.\",\n      \"evidence\": \"Whole exome sequencing in multiple families; mutant channels showed ER retention, protein instability, absent/reduced current; co-expression with WT demonstrated dominant-negative effects rescued partially by KChIP2\",\n      \"pmids\": [\"23280837\", \"23280838\", \"25854634\", \"31293010\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which cerebellar neuron subtypes are most vulnerable not defined\", \"Whether KChIP rescue is therapeutically exploitable not tested\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"KCND3 gain-of-function mutations linked to Brugada syndrome demonstrated that excessive Ito causes J-wave arrhythmias by eliminating the action potential dome.\",\n      \"evidence\": \"L450F and G600R mutations co-expressed with KChIP2 in HEK293 cells showed 50–146% increased peak current; Luo-Rudy simulation modeled dome loss\",\n      \"pmids\": [\"21349352\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Patient-derived cardiomyocyte validation not performed\", \"Whether other Ito-related genes modify penetrance not examined\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"SEMA3A was identified as a novel direct Kv4.3 inhibitor acting through the toxin-binding domain, revealing a non-canonical extracellular regulation of Ito independent of surface expression changes.\",\n      \"evidence\": \"Co-IP confirmed physical Kv4.3–SEMA3A interaction; domain mutagenesis disrupted inhibition; current reduction without surface expression change in HEK293 and hiPSC-cardiomyocytes\",\n      \"pmids\": [\"24963029\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether endogenous SEMA3A levels regulate cardiac Ito in vivo unknown\", \"Binding affinity and stoichiometry not quantified\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Combinatorial assembly of distinct KChIP and DPP isoforms with Kv4.3 was shown to determine cell-type-specific firing phenotypes in hippocampal interneurons, establishing auxiliary subunit identity as the primary determinant of functional diversity.\",\n      \"evidence\": \"Patch clamp, immunohistochemistry, and transcriptomics in CCK⁺ interneurons showed KChIP1 vs. KChIP4e/DPP6S produce distinct firing despite comparable Kv4.3 levels\",\n      \"pmids\": [\"32490811\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether auxiliary subunit composition changes dynamically with activity not known\", \"Contribution of Kv4.2 heteromers not fully excluded\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Kv4.3 downregulation in trigeminal nociceptors was shown to underlie cold hypersensitivity after nerve injury, and pharmacological Kv4.3 potentiation reversed cold allodynia, validating Kv4.3 as a pain target.\",\n      \"evidence\": \"Immunostaining and patch clamp in TG neurons after ION-CCI; phrixotoxin-2 recapitulated allodynia; Kv4.3 potentiation alleviated it behaviorally\",\n      \"pmids\": [\"33472822\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the Kv4.3 potentiator drug and its selectivity profile not fully characterized\", \"Whether central Kv4.3 changes also contribute not addressed\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"High-resolution structures of intact Kv4.3 channel complexes with auxiliary subunits, the precise stoichiometry and spatial organization of the native macromolecular complex, and the relative contributions of Kv4.3's conducting versus CaMKII-scaffolding functions to cardiac and neuronal disease remain to be determined.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No cryo-EM or crystal structure of the full Kv4.3–KChIP–DPP ternary complex\", \"Relative pathogenic contribution of ion conduction loss vs. CaMKII desequestration not dissected in disease models\", \"Therapeutic potential of auxiliary-subunit-targeted interventions for SCA19/22 untested\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 1, 2, 6, 20, 29]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [28, 33]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 6, 9, 14, 28, 32]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [32, 39]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [4, 19]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [2, 20, 29, 40, 41, 42]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [7, 14, 17, 21, 27, 28]},\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [0, 1, 6, 31]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [31, 32, 38, 39]}\n    ],\n    \"complexes\": [\n      \"Kv4.3/KChIP2/DPPX ternary channel complex\",\n      \"Kv4.3/AT1R/KChIP2 signaling complex\",\n      \"Kv4.3/CaMKII scaffolding complex\"\n    ],\n    \"partners\": [\n      \"KCNIP2\",\n      \"KCNIP1\",\n      \"KCNIP3\",\n      \"DPP6\",\n      \"DPP10\",\n      \"KCNAB2\",\n      \"KCNE2\",\n      \"AGTR1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}